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1. INTRODUCTION 
In recent years ample evidence has been accumulated that estrogens are essential 
for normal male fertility and that they likewise may also interfere with fertility. Thus a 
series of male reproductive disturbances, such as cryptorchidism, epididymal defects, 
impaired fertility and an increased incidence of testicular cancer (McLachlan et al., 1975a, 
b, Gill et al., 1979, Jensen et al., 1995; Raman-Wilms et al., 1995, Saunders et al., 1997, 
Cooper and Kavlock 1997, Toppari and Skakkebaek 1998, Toppari et al., 1996) has been 
reported to occur after administration of estrogens and xenoestrogens during fetal and 
neonatal development. 
The opinion that estrogens are essential for male fertility, however, was delayed 
until a knockout mouse (KO) (Lubahn et al., 1993, Korach 1994, Eddy et al., 1996) and rat 
(Hess et al., 1997) lacking a functional estrogen receptor  (ER) gene (ERKO) was 
developed. While the infertility observed in the ERαKO mouse for the first time 
demonstrated that estrogens are required for male fertility (Lubahn et al., 1993), it was the 
observations in the ERKO rat that revealed that the infertility is primarily due to a defect 
in efferent ductule development and function (Hess et al., 1997, Lee et al., 2000). Mice 
lacking a functional aromatase gene (ArKO) are also infertile, probably due to a specific 
defect in germ cell development (Robertson et al., 1999). Thus although estrogen receptor 
 (ERβ) knockout mice (ERKO) seem to have a normal phenotype, observations in 
ERKO, in ERKO (Couse and Korach 1999, Dupont et al., 2000), in ArKO mice 
(Honda et al., 1998, Robertson et al., 1999) and in aromatase-inhibited Leydig cells 
(Kmicikiewicz et al., 1997), provide compelling evidence for a likelihood of estrogens 
being involved in spermatogenesis. 
Apart from being important regulators of epididymal development and function 
(Toney and Danzo 1989; Dhar et al., 1998) estrogens also synergize with 5-reduced 
androgens to induce prostate gland growth as observed in the dog (Walsh and Wilson 
1976, Markham and Coffey 1994, Suzuki et al., 1994). 
A particular situation seems to exist in the boar. The boar is remarkable for its high 
levels of testicular estrogen secretion (Velle 1958, Reaside 1965, Claus and Hoffmann 
1980, Reaside et al., 1993, Rostalski et al., 2000, Rostalski 2005) as well as for its 
exceedingly large volume of semen (200–500 ml) and output of spermatozoa (30-60 
x109/ejaculate) (McKenzie et al., 1938, Frankenhuis et al., 1982). In respect to biological 
function of estrogens in the boar, earlier work in castrated animals revealed that estrogens 
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act synergistically with testosterone on the accessory sex glands and libido development 
(Joshi and Reaside 1973, Booth 1980). Claus et al. (1987) developed the hypothesis that 
estrogens in the seminal fluid of the boars might play a role in myometrial contraction and 
in synchronising induction of ovulation in females during copulation. However these 
provided no further hints on a likely functional role in the boar himself. 
Metabolism of estrogen in the body occurs mainly in the liver. However, evidence 
has accumulated that local metabolism in target organs may contribute to the overall 
response to the hormone (Zhu and Conney 1998). It was hypothesised that the biological 
effects of an estrogen depends on the profile of multiple metabolites formed, and the 
biological activities of each of the metabolites in the target cells (Reaside et al., 1999). In 
the boar concentrations of estrone sulfate (ES1) exceeds by far those of free estrone (E1) 
(Reaside 1966, Reaside et al., 1998, Rostalski et al., 2000, Rostalski 2005) in testicular 
venous blood and high activities of steroid sulfatase (StS) and a lower activity of estrogen 
sulfotransferase (EST) was observed in testicular homogenates (Rostalski et al., 2000, 
Rostalski 2005). Although their localization was not known, it may be postulated from 
these data that both StS and EST seem important factors that regulate local availability of 
biologically active estrogens in testis of the boar. 
Based on this background information, the hypothesis of the present study was that 
estrogens may have functional roles in the testis of the boar like in other species. In order 
to provide evidence, the expression of ER and ER was tested in conjunction with the 
identification of those cells expressing aromatase, StS and EST. 
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2. LITERATURE REVIEW 
2.1 Anatomy and histology of the boar testis 
2.1.1 Location and gross morphology of the boar testis 
Mature boar testis measure approximately 10 cm in length and 5 to 6.5 cm in width, 
and weigh about 400g (Amman, 1970, Dym and Cavicchia 1978). They descend during 
foetal life from the abdominal cavity to lie extra-abdominally in the scrotum that is located 
in the sub anal region of perineum. 
 
Fig. 1: Morphology of the boar testis. A - intact testes covered by the scrotum, B - intact testis with 
opened scrotum, C - sketched cross section of a testis; i - scrotum, ii – tunica dartos, iii - tunica vaginalis 
(parietal layer), iv - tunica vaginalis (visceral layer), v - blood vessel, 1 - head or upper pole of testis, 2 - 
tunica albuginea, 3 - testicular septa, 4 - free margin, 5 - lateral margin, 6 - tail or lower pole of testis, 7 - 
testicular lobules, 8 - parenchyma of testis, 9 - efferent ductules, 10 - mediastinum testis, 11 -posterior 
margin (Animal Science; http://www.ansi.okstate.edu) 
The scrotum (Fig.1A, i) is composed of an outer layer of thick skin with numerous 
large sweat and sebaceous glands. Its inner layer is lined by the tunica dartos (Fig.1B; ii) 
consisting of fibroelastic tissue and smooth muscle interspersed with connective tissue. 
The tunica dartos divides the scrotum into two pouches and is attached to the tunica 
vaginalis at the bottom of each pouch. The external spermatic fascia from the external 
oblique muscle, the cremaster muscle from the internal oblique muscle and the internal 
spermatic fascia extend between the tunica dartos and vaginalis. The tunica vaginalis lines 
the process vaginalis with an outer parietal layer (Fig.1B; iii) and a visceral layer 
contacting the surface of each testis (Fig.1B; iv). 
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The tunica albuginea (Fig.1C; 2) is a tough capsule that encloses each testis and 
consists mostly of dense irregular fibrous connective tissue, predominantly of collagen- 
and a few elastic fibres. The capsule is probably involved in maintaining fluid pressure 
inside the testis or in moving fluid and sperm into the epididymis. The tunica albuginea has 
blood vessels (Fig.1B; v) from the numerous branches of the testicular artery and vein. 
The tissue trabeculae or the septula testis (Fig.1C; 3) originate from the tunica 
albuginea and converge centrally to form the loose connective tissue of the mediastinum 
testis (Fig.1C; 10). The trabeculae or septula testis, composed predominantly of collagen 
fibres, contain blood vessels and nerves and divide the testis into a varying number of 
testicular lobules (Fig.1C; 7), each containing one to four convoluted seminiferous tubules. 
In the boar, like in most other domestic mammals, the mediastinum testis occupies a 
central position of the testis. Within the mediastinum testis are the channels of the rete 
testis by which the spermatozoa and the fluid, in which they are suspended, leave the testis. 
The rete testis is lined by a simple squamous-, cuboidal-, or columnar epithelium and it is 
connected to the cephalic portion of the epididymis by efferent ductules (Fig.1C; 9) (for 
review see Wrobel 1998). 
Thus the parenchyma of the testis (Fig.1C; 8) consists of seminiferous tubules 
separated by interstitial tissue. The bulk of the testicular tissue is the seminiferous tubules 
and in the boar, they comprise about 60-70 % of the testis. The outer wall of each 
seminiferous tubule is a single layer of boundary tissue cells, the myoid- or peritubular 
contractile cells that are similar in some ways to smooth muscle cells (Allrich et al., 1983, 
Wrobel 1998). Between the seminiferous tubules in the interstitial region, there are the 
peritubular capillaries, the venous and lymphatic vessel networks, nerves and the Leydig 
cells. 
A supporting system consisting mainly of various suspensory ligaments maintains 
the testis in its scrotal position. The ligamentum proprium testis that originates from the 
head or the upper pole of the testis connects and anchors the testis to the tail of the 
epididymis and the ligamentum cauda epididymis suspends and anchors the tail of the 
epididymis onto the fundus of the vaginal process. These ligaments are part of the 
degenerated gubernaculum testis that acted to direct and guide the testis into the scrotum 
during its descent from the abdominal cavity (for review Schummer et al., 1987). 
The spermatic cord also partially contributes to the support system of the testis. It 
runs from the abdomen and is attached to the testes in the scrotum. It is a band of tissue 
LITERATURE REVIEW 
   
15 
that carries the ductus deferens, blood vessels, nerves and muscles associated with the 
testis. In the boar it is 8 to 10 inches or more in length (Wrobel 1998). 
2.1.2 Vascular supply and innervations 
The testis is supplied by two arteries, the internal spermatic artery originating 
directly from the aorta and the ductus deferens artery coming from the urogenital artery. 
The two arteries finally branch into unevenly distributed small non-fenestrated blood 
capillaries, which are associated with the lamina propria of the seminiferous tubules but 
also are interspersed among interstitial cells. The capillaries of scrotal testes are about 
10µm in diameter and contain an endothelial layer formed by two cells, a basal lamina 
constituted by collagen fibres and glycoconjugates, and a pericyte layer formed by a single 
cell (for review see Pinart et al., 2001a). 
The testis drains its blood through the testicular veins, which then form a 
pampiniform plexus around the internal spermatic artery and finally drain into the caudal 
vena cava. The testicular veins in the boar can be subdivided into 4 types according to their 
perivascular elements and their location to the testicular artery. A type I vein is a large vein 
which gives rise to type II and III veins. Type II vein is composed of a single layer of veins 
that run along the testicular artery, while type III vein is composed of several layers of 
veins that are located between type II veins. The Type IV vein is regarded as a venous 
portal system and is composed of small muscular and pericytic venules located in the 
tunica adventitia of type II veins and the testicular artery. Occasionally type IV veins 
penetrate deep into the tunica media of the testicular artery to provide a fenestrated 
endothelium in its thin portion. A direct arterio-venous anastomosis between the 
pampiniform plexus and the testicular artery is not found in the boar and Type IV veins are 
considered the most important vessel in reducing the capacity of the barrier between the 
testicular artery and the type II and III veins. It is therefore suggested that type IV venous 
network may play a role in transferring the substances between the artery and the veins (for 
review see Rerkamnuaychoke et al., 1991). Between the seminiferous tubules in the 
interstitial region there are lymphatic vessel networks through which the testis drains its 
lymphatic fluid via the lumbar lymph nodes (Pinart et al., 2001b). 
Nearly all the testicular nerves represent postganglionic sympathetic axons from the 
lumbar sympathetic trunk that reaches the gonad by three different routes - the funicular, 
caudal and mesorchial route. These axons innervate the vascular structures of the spermatic 
cord, the tunica albuginea, nearly all the septula testis and the mediastinum. Only in 
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exceptional cases are axons in contact with Leydig cells. From their association with blood 
vessels, the majority of nerves are vasomotoric in function. 
Innervations of the porcine testes remarkably change during the period from birth to 
adulthood, with the most intense innervation found in testes of piglets aged 3 to 5 weeks. 
In 7- to 10-week old pigs, testicular innervation shows varying degrees of withdrawal and 
the testes of adult boars are completely devoid of intrinsic nerves. Only the funicular 
nerves supplying the testicular artery and pampiniform plexus are preserved in the adult 
age group. So, the vasomotoric control of intratunical, septal and mediastinal vessels and 
of the complete microcirculation within the testicular parenchyma is accomplished without 
any direct nerve participation in the sexually mature boar (for review see Wrobel and 
Brandl 1998). 
2.1.3 Temperature regulating system 
The testis requires cooler (2-8°C) temperature below that of the body for normal 
spermatogenesis. An important purpose of the scrotum is to act as a temperature-
controlling device. In the boar the scrotum is less pendulous and sweating is less efficient, 
which may explain the observed small difference between its scrotal and rectal 
temperatures of 2.3C (Stone 1981). Another mechanism in temperature regulation is 
through the cremaster reflex; thus the external cremaster muscle within the spermatic cord 
draws the testes closer to the abdomen when cold and relaxes them away from the 
abdomen when warm. The tunica dartos muscle at the bottom of the scrotum also responds 
to temperature changes. It has also been shown that this muscle is sensitive to temperature 
changes only in the presence of testosterone (Stone 1981). Blood flowing to the testis is 
cooled by the adjacent venous return in the convoluted complex of the pampiniform plexus 
located just dorsal to the testes. 
2.1.4 Brief histology of the boar testis 
2.1.4.1 General histology 
The histological appearances of the seminiferous tubules (ST) in mature- and in 
immature testes is different (Russell et al., 1990, Livera et al., 2000). Testicular histology 
of immature testis is characterised by ST dominated by Sertoli cells with few 
prespermatogonia (gonocytes) and a not yet developed lumen. The mature testis shows ST 
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characterised by the presence of germ cells from all stages of a fully developed 
spermatogenesis and lumina that are fully developed. In most mammals the ST is tortuous 
with a diameter between 150 and 300 µm and is lined by a stratified germinal epithelium 
consisting of two different basic cell types - sustentacular (supporting, Sertoli) cells and 
spermatogenic cells (Russell et al., 1990, Wrobel et al., 1988). Although 
immunohistological staining might not allow true revelation of the 8 stages of 
spermatogenesis that occur in the boar (Swierstra 1968a and b), tubules in different 
sparmatogenic phases can be easily recognised, and, as described by Kohler (2004), 
spermatogenesis can grossly be divided into three arbitrary phases, the first one 
immediately after spermiation without elongated spermatids, the second one during 
elongation of the spermatids and the third one just prior to spermiation with fully elongated 
spermatids. 
2.1.4.2 Sertoli cells 
The Sertoli cells or sustentacular cells (named after the Italian histologist Enrico 
Sertoli, 1842-1910) are easily identifiable by their nucleus. They are not part of the sperm 
cell line, but "nurse" cells that sustain the proper environment for spermatozoa to develop 
(Griswold 1998). Although a Sertoli cell has a very extensive and branching cytoplasmic 
structure, little of the Sertoli cell's true extent can be seen in the light microscope (Russell 
1993a, b). 
The extensive branching nature of the Sertoli cell's cytoplasm and its role in 
isolating the haploid cells of spermatogenesis from the rest of the body (Fig.2) were 
understood with the advent of the electron microscope (EM). Their shape is columnar but 
highly irregular; they extend from the basement membrane to the luminal surface of the 
seminiferous epithelium and their processes extend in between the spermatogenic cells. 
The nucleus of Sertoli cell is ovoid or angular, large and lightly stained, slightly separated 
from the tube border and often contains one or two prominent nucleoli. The long axis of 
the nucleus is oriented perpendicular to wall of the tubule. A fold in the nuclear membrane 
is characteristic for Sertoli cell but not always visible in the light microscope (Chevalier 
1978, Schulze 1984, Russell 1993a, b, de Kretser and Kerr 1994).  
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Fig. 2: Structure of Sertoli cell (1).  A - histological section, B - electron micrograph, C - plastic model 
(Russell 1993a, Courtesy of Prof. Rex Hess, Illinois). 
Sertoli cells hold germ cells in crypts in their luminal surface, thus maintaining the 
architecture of the seminiferous epithelium (Chevalier 1978, Dym and Cavicchia 1978, 
Russell 1993a, b, de Krestser and Kerr 1994). The base of the Sertoli cell sits on the basal 
membrane of the seminiferous tubule. The cell's lowest "branches" reach out to those of 
other Sertoli cells and when these processes make contact, they fuse to form long 
occluding (tight) junctions that effectively separate the tubule into two compartments - one 
is "below" (or outside of) the fused lower processes (the adluminal or basal compartment), 
and the other is "above" them, on the side open to the tube (the luminal compartment) 
(Yazama et al., 1988, Russell 1993a, b). These occluding junctions form the blood testis 
barrier. As a result blood borne components of the immune system are denied access to the 
luminal compartment containing the haploid stages of sperm development. Simultaneously 
the blood-testis barrier also permits the maintenance of different environments for different 
stages of sperm development and acts to conserve certain products of Sertoli cells within 
the seminiferous tubule, such as Androgen Binding Protein (ABP) (Yazama et al., 1988). 
As spermatocytes develop from spermatogonia, they are moved into the luminal 
compartment by the appropriate Sertoli cells which grow new processes, which then 
"undermine" the germ cells that are ready to move up. After this has happened, the 
junctions "above" them are broken and these germ cells are now (without having passed 
through any junctions) no longer in the compartment accessible to the blood - they leave 
the adluminal- and enter the luminal compartment (Russell 1977; Pelletier and Byers 1992; 
Lui et al. 2003). 
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Sertoli cells are involved in anchoring and nourishing germ cells, forming blood 
testis barrier, phagocytosing residual bodies, releasing sperms during spermiation, and 
participating in secretion and endocytosis of various substances, including ions and water. 
They transport water from the interstitial space into the lumen, serving as the vehicle for 
moving sperms from the testis to the epididymis. Sertoli cells are also responsible for 
secretion of numerous proteins into the seminiferous tubular lumen, such as glycoprotein 
androgen binding protein (ABP), which binds androgens with high affinity and transports 
them to the epididymis. Additionally they reduce testosterone into dihydrotestosterone and 
secrete inhibin and activin, hormones regulating FSH-release (Clermont 1972, Schulze 
1984, de Kretser and Kerr 1988, Russell 1993c, Dadoune 1994, Grover et al., 2004). 
2.1.4.3 Leydig cells  
Interstitial cells (or Leydig cells named after a German anatomist Franz von 
Leydig, 1821-1908) appear as small groups of cells in the interstitial regions between the 
seminiferous tubules. Leydig cells are 15-20 µm in size, cuboidal in shape and appear in 
clusters of 2-20 cells. Their cytoplasm is strongly acidophilic, finely granular and their 
nucleus is large, round and often located eccentric in the cell (Christensen 1975, Desjardins 
and Ewing 1993). They are extremely abundant in the boar making the lymphatic vessels 
quite inconspicuous (Belt and Cavazos 1967). Their characteristics in the testis of the boar 
were revealed by Belt and Cavazos (1967) with the aid of an EM: The bulk of the 
cytoplasm to one side of an eccentrically placed nucleus consists predominately of a tightly 
packed agranular endoplasmic reticulum in a system of anastomosing tubules. Free 
ribosomes and a few short strands of granular endoplasmic reticulum are present only in a 
perinuclear or subplasmalemmal location. Mitochondria are abundant as a cluster in the 
centre of the cytosome. Surrounding them are dense bodies. Between contiguous cells, 
irregularly disposed microvilli protrude into an intercellular space of variable dimensions. 
Some sites of membrane fusion, resulting in maculae occludentes, are observed between 
adjacent cells, while occasionally small desmosomes are observed. Coated vesicles are 
frequent near to and continuous with the plasmalemma as well as deeper within the cell, 
especially in association with elements of the Golgi apparatus. 
In the boar these cells secrete not only androgens but also abundant amounts of 
sulfo-conjugated estrone (Claus and Hoffmann 1980, Ford 1983, Reaside and Renaud 
1983, Setchell et al., 1983, Claus et al., 1987, Rostalski et al., 2000). In addition, 
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expression of aromatase in the boar Leydig cell (Conley et al., 1996, Biliniska et al., 2000, 
Fraczek et al., 2000, Mutembei et al., 2005b), and activity of sulfatase and of 
sulfotransferase (Rostalski 2005) within its testis has been observed. 
2.1.4.4 Spermatogonia  
Spermatogonia are diploid and the first cells along the route of spermatogenesis. 
They are always situated in contact with the basal membrane of the seminiferous tubule. 
Subsets of type A spermatogonia (A0), which are the true stem cells of the germ cell 
population (Clermont 1972), multiply mitotically to form new generations of type A0-stem 
cells and type A1 spermatogonia. While the A0 spermatogonia enter a phase of arrest, the 
A1-spermatogonia divide further into A2, A3, A4, intermediate and B spermatogonia 
(Swierstra 1968a, b; Frankenhuis et al., 1982). 
Type A spermatogonia have a rounded to oval nucleus with fine chromatin grains 
and one or two nucleoli, the type B spermatogonia have a more rounded nucleus with 
chromatin granules of variable sizes that are often attached to the nuclear membrane and 
contains one nucleolus. Division of type B spermatogonia is the final mitosis resulting in 
the formation of primary spermatocytes (Browder et al., 1991). 
2.1.4.5 Primary spermatocytes 
Primary spermatocytes and the following stages lie in the cell layer luminal to the 
spermatogonia. They immediately enter the prophase of the first meiotic division. Primary 
spermatocytes appear larger than spermatogonia and a large number of them are always 
visible in a seminiferous tubule cross-section. A primary spermatocyte has a round nucleus 
with fine chromatin granules and one nucleolus. Cell divisions, from the formation of 
primary spermatocytes and onwards to the production of elongated spermatids, are 
incomplete and the cellular associations remain connected by bridges of cytoplasm that 
appear as clonal units (Dym and Fawcett 1971, Weber and Russell 1987). 
2.1.4.6 Secondary spermatocytes  
Each primary spermatocyte divides meiotically to form two haploid secondary 
spermatocytes with 2N, which then divide to form four haploid spermatids with 1N. 
Secondary spermatocytes are smaller than primary spermatocytes. They rapidly enter and 
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complete the second meiotic division and are therefore rarely seen in histological 
preparations. Two important events with major genetic consequences occur during the two 
meiotic divisions - there is the random separation of homologous chromosomes and 
crossing over of genetic material, a process that maintains individual genetic specificity 
(Dym and Fawcett 1971, Weber and Russell 1987, Russell 1993c). 
2.1.4.7 Spermatids  
The initial forms are small (about 10 µm in diameter) and contain a very light-
staining (often eccentric) nucleus (Dadoune 1994). The chromatin condenses highly during 
maturation of the spermatids into spermatozoa, a process that results in a smaller and 
darker staining nucleus. The development of spermatids from meiosis to detachment of the 
spermatozoa is known as spermiogenesis (Fawcett et al., 1970). During this process the 
cell changes from a simple rounded cell into a highly differentiated spermatozoon by 
undergoing complex morphological, physiological and biochemical changes (Dooher and 
Bennett 1973, Gilbert 2000). 
2.1.4.8 Spermatozoon 
The spermatozoon is the final product of spermatogenesis. The structure of the 
mammalian spermatozoon, including that of the boar, has been broadly studied and 
documented (Clermont 1972, Peterson et al., 1987, Browder et al., 1991, Shostak 1991, 
Curry and Watson 1995, Kalthoff 1996, Gilbert 1997, Wolpert et al., 1998). Briefly, it is 
divided into head, neck and tail. In the boar it is about 50 µ long, the head is about 5 µ 
long, 4 µ wide and 0.5 µ thick and chiefly consists of the flattened nucleus. The anterior 
2/3 of the nucleus is covered by the acrosome which originates from the Golgi apparatus 
and contains enzymes important in the process of fertilisation. The neck (about 1 µ) is 
formed by the posterior part of the nuclear membrane and attached to the basal plate. A 
transversely oriented centriole is located immediately behind the basal plate. The neck also 
contains segmented columns of fibrous material that continue as the outer dense fibres into 
the tail. The tail is further divided into middle-, principal- and end piece. The axonema (the 
generic name for the arrangement of microtubules in all cilia) originates in the neck and 
extends through the end piece; it is surrounded by the outer dense fibres through the 
principal piece. The middle piece is about 8-10 µ long and terminated by a dense ring, the 
annulus; a sheath of mitochondria surrounds its axonema and dense fibres. The principal 
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piece is about 35-40 µ long. It contains a fibrous sheath, which consists of dorsal and 
ventral longitudinal columns interconnected by regularly spaced circumferential hoops; it 
does not extend to the tip of the tail. The end-piece is about 3-5µ. Motility of the 
spermatozoon is achieved after epididymal maturation (Wrobel 1998). 
2.1.4.9 Lamina propria 
The peritubular sheath of cells and the basal lamina form the two main components 
of the tubular lamina propria. Pinart et al. (2001a) reported the constitution of lamina 
propria in the boar to consist of an innermost non-cellular layer, referred to as the basal 
lamina, surrounded by 2 layers of peritubular cells that are separated by a fibrous layer. 
The non-cellular layer consists of collagen fibres and glycoconjugates with abundant N-
acetylgalactosamine, galactose, fructose, N-acetylglucosamine and neuraminic acid 
residues. The inner peritubular cell layer is composed of myoid cells while the outer layer 
is composed of fibroblasts. The myoid or peritubular contractile cells have a spherical to 
rounded nucleus and are similar in some ways to cells of the smooth muscle. The basal 
lamina is the inner component of the lamina propria that covers the entire circumference of 
the seminiferous tubules and it is bound to the outer peritubular myoid cells by collagen 
and elastic fibres. The lamina propria is implicated in tubular contractility, in 
complementing the blood-testis barrier and in mediating the communication and the 
substrate diffusion between seminiferous tubules and interstitial tissue (Wrobel 1998). 
2.2 Testicular and ductal system development and function 
2.2.1 Fetal period 
In male as well as in female embryos the gonads develop from an identical 
indifferent bipotential genital ridge (Klaus, 1996), a sub-region of the urogenital ridge. The 
epithelium of the coelomic cavity lines the urogenital ridge and serves as the source of 
multiple gonadal cell lineages (Schmahl et al. 2000). 
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Fig. 3: Summary of genes essential for development of the testis. Solid lines indicate activating 
effects while dotted lines indicate inhibition effects. 
Various genes play vital roles in the development of the testis (Fig. 3). 
Establishment of the bipotential genital ridge requires expression of Wilms’ tumour 
suppressor gene (WT-1) and SF-1 (steroidogenic factor-1) (Luo et al., 1994, Achermann et 
al., 1999, Bakke et al., 2001) in both sexes during early embryonic development. 
According to our present understanding further differentiation into an ovary requires no 
special stimuli (principle of basic femaleness) while differentiation into a testis and the 
development of the male phenotype require specific signals. Differentiation is initiated 
when primodial germ cells, which might carry either the XX or XY combination, reach the 
indifferent bipotential gonadal ridge; male (XY) primodial germ cells migrate and reach 
into the male-signalling mark (Martineau et al., 1997) while the XX primodial cells get 
stuck in the cortex (Adams and McLaren 2002). The exact cellular origin of primordial 
germ cells (PGCs) is unknown (Ginsburg et al. 1990) but their ancestors are thought to 
arise from a pool of epiblast cells (cells of the heterogeneous, undifferentiated ectodermal 
tissue) (Kierszenbaum and Tres 2001). 
Further development of the testis is triggered by SRY-factor (Sex determining 
Region on Y chromosome), a Y chromosome-linked gene. Deletions or mutations of the 
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SRY gene lead to XY female development (Gubbay et al., 1990, Lovell-Badge and 
Robertson 1990, Sinclair et al., 1990, Schmahl et al., 2000, Hawkins et al., 1992, Ikeda et 
al., 1994) and even reduced SRY expression causes XY sex reversal or ovotestis 
(Nagamine et al., 1999, Hammes et al., 2001, Washburn et al. 2001). A close relative of 
SRY is the SOX-9 gene - a gene containing the high mobility group (HMG) box domain of 
transcription factors and expressed in testes of all vertebrates (Kent et al., 1996, Morais da 
Silva et al., 1996, Bowles et al., 2000, Nagai 2001). Its mutations result in XY sex-reversal 
whereas ovarian development is normal, demonstrating that it is necessary for testis 
determination (Foster et al., 1994, Wagner et al., 1994, Koopman 1999). Furthermore 
SOX-9 expression in ovaries results in female-to-male sex reversal (Huang et al., 1999, 
Bishop et al., 2000, Vidal et al., 2001), which means, it may represent an ancestral sex-
determining gene and mammals have evolved SRY as a Y-linked switching mechanism 
(Nagai 2001). Based on its expression pattern, SOX-9 serves as a putative target gene for 
SRY, although definitive proof for this is still lacking. 
Although to date no target genes for SRY have been identified, its expression 
pattern in the mouse indicates that it initiates the differentiation of gonadal supporting-cell 
precursors, which are derived from the coelomic epithelium, to develop as testicular Sertoli 
cells (Hacker et al., 1995, Albrecht and Eicher 2001). Sertoli cells, which surround germ 
cells to form testicular cords in prenatal gonads (Karl and Capel 1998), proliferate and 
reach maximum numbers before birth (Orth 1982). The Fibroblast growth factor-9 (FGF-9) 
gene regulates the SRY-dependent processes, such as cell proliferation and migration of 
coelomic cells into the gonad, and further Sertoli cell differentiation. Male mice lacking 
this gene exhibit phenotypes ranging from hypoplasia to complete sex reversal (Colvin et 
al., 1999, 2001). 
SRY may be counteracted by a nuclear receptor gene referred to as DAX-1 (Yu et 
al., 1998). DAX-1 gene duplication results in male-to-female sex-reversal (Zanaria et al., 
1994) while its mutation leads to hypogonadotrophic hypogonadism (Tabarin et al., 2000). 
DAX-1 gene is co-expressed with SF-1 along the developing hypothalamic-pituitary-
gonadal axis in the gonads of both sexes (Ikeda et al. 1996) where it may repress and/or 
modulate SF-1-mediated activity in the gonads for normal development (Wang et al. 
2001). 
Sertoli cell signalling is essential for further testicular development (Magre and Jost 
1991); it enables the primordial germ cells to proliferate mitotically (McLaren 2000) and to 
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differentiate into gonocytes (prespermatogonia) that undergo mitotic arrest until birth when 
they resume proliferation (Sutton 2000, de Rooij 2001). 
Leydig cell precursors originate either from the adjacent mesonephros or from the 
cells of the coelomic epithelium and migrate into the genital ridge (Buehr et al., 1993, 
Merchant-Larios and Moreno-Mendoza 1998; Karl and Capel 1998, Yao and Capel 2002). 
The fetal Leydig cells present at birth are not progenitors of the adult Leydig cell 
population; rather they remain present in low numbers in the mature testis, presumably in a 
quiescent state (Kerr and Knell 1988). 
The ductal system arises from a structure adjacent to the genital ridge called 
mesonephros that regresses during embryonic development. In the male, both testosterone 
of Leydig cell origin and Müllerian inhibiting substance (MIS, also known as anti-
Müllerian hormone, AMH), secreted by embryonic/fetal Sertoli cells, are needed for 
development of the male phenotype. Notably the steroidogenic factor-1 (SF-1) (Lala et al., 
1992, Morohashi et al., 1992, Parker and Schimmer 1997) regulates this endocrine-
dependent step of sex determination. MIS causes the regression of Müllerian ducts and 
testosterone and its derivative, dihydrotestosterone, stimulate the development of male-
type genitalia (Behringer et al., 1994, Rey and Picard 1998). Male duct development can 
be inhibited if steroid production is down regulated by WNT-4 gene or if antiestrogens are 
applied (Vainio et al., 1999). 
2.2.2 Post natal and mature period 
The testis of a newborn animal is functionally an immature organ. For normal 
spermatogenesis, the correct gonadal position is essential and testicular descent from the 
fetal retroperitoneal position into the scrotum is initiated during the prenatal period. This 
activity is regulated by the INSL-3 gene (also known as relaxin-like factor) - disruption of 
this gene causes bilateral cryptorchidism (Zimmermann et al., 1999, Adham et al., 2000). 
In most species the number of Leydig cells remains fairly constant from the late 
fetal period throughout the postnatal period. However in the boar, Herrera et al. (1983) 
reported abundant hyperplastic Leydig cells from 14 to 40 days postpartum, which 
thereafter decreased not only in number but also in size. Their numbers remained 
constantly low until the prepubertal period, when a second rapid increase was observed, 
yielding the final population of adult Leydig cells (Nistal et al., 1986, Hardy et al., 1991, 
Habert et al., 2001). When compared to juvenile Leydig cells, the adult Leydig cells 
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(Christensen 1975, de Kretser and Kerr 1988, Hardy et al., 1991) have a marked increase 
in volume of smooth endoplasmic reticulum (SER), rough endoplasmic reticulum (RER), 
Golgi vesicles and mitochondria. In addition, there is a rise in the total number of 
mitochondria per cell. In the boar these changes occurs between 100 and 130 days of age 
(Lunstra et al., 1986, Franca et al., 2000, Tripepi et al., 2000). These ultra structural 
characteristics are consistent with an increased capacity for the secretion of steroids by 
individual Leydig cells (de Kretser 1967, Kerr et al., 1979, Zirkin et al. 1980). The sharp 
increase in number of LH receptors per Leydig cell between 100 and 130 days in boars 
may be a causative factor in the subsequent hypertrophy of the Leydig cell at 130-160 days 
of age (Lunstra et al., 1986). 
Differentiation of Sertoli cells commences during puberty (de Kretser and Kerr 
1988), with the number of the Sertoli cells in the testis remaining stable throughout 
adulthood (Wang et al., 1989). 
After birth prespermatogonia differentiate into spermatogonia and at puberty, 
spermatogenesis begins. In the boar onset of spermatogenesis is around day 80 and from 
90 days on, pachytene primary spermatocytes could be found (Allrich et al., 1983, Herrera 
et al., 1983). 
2.2.3 Spermatogenesis in the boar 
During spermatogenesis spermatogonia (A1) undergo successive mitotic and 
meiotic divisions and metamorphic changes (spermiogenesis) to produce spermatozoa 
(Swierstra 1968a, b, Clermont 1972, Frankenhuis et al., 1982, Hess 1990, Browder et al., 
1991). Duration of the spermatogenic process in man and farm animals is about two 
months, in the boar it is 39 days. 
Spermatogenesis is inherently linked to the process of apoptosis (Jacobson et al., 
1997, Raff 1998), a process that serves a role in regulating the development and survival of 
germ cells (Dunkel et al., 1997, Matsui 1998, Sinha Hikim and Swerdloff 1999, 
Kierszenbaum and Tres 2001). A balance between germ cell survival and death is a 
prerequisite for normal spermatogenesis and testis development. Before reaching maturity, 
a number of germ cells undergo physiological apoptotic death, which has been showed to 
be under genetic and hormonal control (Matsui et al., 1998, Braun 1998, Sinha and 
Swerdloff, 1999). FSH (Dunkel et al., 1997a), Testosterone, (Erkkilä et al., 1997) and 
estradiol (Pentikainen et al., 2000) are part of factors that promote germ cell survival. 
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Some of the genes known to support cell-survival include those for the Bcl-2 family of 
proteins and Bax (Rodriguez et al., 1997, Russell et al., 2002), the spermatogenic stage-
specific transcription factors GATA-1 and GATA-4 and their cofactors FOG-1 and FOG-2, 
all of which largely act in anti-apoptotic process (Ketola et al., 1999, 2002). On the other 
hand the caspases, which are cell death-promoting enzymes, inactivate GATA-1 and -4 
transcription factors (De Maria et al., 1999), thereby promoting cell death. 
2.2.3.1 Spermatogoniogenesis, stem cell renewal and spermatocytogenesis 
Spermatogonia stem cells proliferate by mitosis through several different types of 
spermatogonial population to provide a source for 30-60 x109 of spermatozoa that are daily 
produced in the boar testis (McKenzie et al., 1938, Frankenhuis et al., 1982). In this 
species, four classes of spermatogonia are observed; undifferentiated A spermatogonia 
(A1), differentiating A spermatogonia (A2, A3), intermediate and B spermatogonia. 
Mitosis ends when B type spermatogonia yield two preleptotene primary spermatocytes 
(Russell et al., 1990), a process that yields 16 primary spermatocytes from each of the A2 
spermatogonia (Fig. 4) and takes about 7-10 days in the boar (Swierstra 1968a, b, 
Frankenhuis et al., 1982). 
 
Fig. 4: A Schematic representation of spermatogenesis 
Spermatogenesis is dependent on the replenishment of spermatogonial stem cell 
(A1). The mechanisms of germ cell renewal are not totally understood and there are 
presently two schools of thought. It has been a long standing opinion that  a stem cell (A1) 
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probably divides into an A2 spermatogonia and an operative copy of itself as indicated in 
figure 4 (Clermont 1972). The more recent thought is that A1 divides only into A2 types 
and that certain Sertoli cell-derived factors influence the conversion of some of the A2 
spermatogonia into A1 stem cells to be kept in reserve for future divisions while the rest of 
A2 cells become dedicated to spermatogenesis (Chen et al., 2005). These Sertoli cell-
derived factors are secreted under the regulation of ERM, an Ets (epithelial specific 
protein) Related Molecule and a Pea3 subfamily (Ets transcription factor). ERM is 
expressed exclusively in Sertoli cells and it is essential for the regulation of spermatogonial 
stem cell self-renewal because it has been shown that ERM-/- males undergo only a first 
wave of spermatogenesis that is normal, but subsequent waves are lost through maturation 
depletion of germ cells, resulting in sterility. Testes from ERM-/- mice aged 3 months or 
older exhibit complete seminiferous tubular atrophy, characterized by depletion of all germ 
cells, but retention of Sertoli cells (Chen et al., 2005). 
Meiosis 1 is initiated in preleptotene spermatocytes. In interim phase and prior to 
reducing haploidity with 2N, DNA-content in primary spermatocytes is 4N. This doubling 
of chromosomes is associated with doubling in cell size. These synthetic processes take 
time and this is the most prolonged period in spermatogenesis (Swierstra 1968a, b, 
Clermont 1972, Russell et al., 1990). During meiosis 1, primary spermatocytes are 
transformed into two secondary spermatocytes (2N), which then in turn are converted into 
four round haploid (1N) spermatids during meiosis II. The second meiotic division is rapid 
and therefore very few secondary spermatocytes can be identified in histological sections 
(Clermont 1972). 
Whereas meiosis II is essentially like a mitotic division, meiosis I is different in that 
during this process, homologous chromosomes pair along their length and come in contact 
in discrete areas of synapsis (chiasmata), through which chromatids exchange base pairs by 
crossing-over. This allows for generation of genetic variability and also provides a 
mechanism for correcting damage in the DNA helix; the repair mechanisms ensure that 
precision in the DNA of the gametes is sustained (Creasv et al., 1985). 
2.2.3.2 Spermiogenesis  
Spermiogenesis defines the phase where round spermatids turns into the mature 
elongated spermatids ready for spermiation (Leblond and Clermont 1952b; Russell et al., 
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1990). This process is divided into Golgi phase, cap phase, acrosomal phase and 
maturation phase. 
In brief, during the Golgi phase, the centrioles, which serve as points of 
organization of spindle fibres, migrate to a postnuclear region. The acrosome is derived 
from the Golgi apparatus (Susi et al., 1971); proacrosomal granules fuse to form a single 
acrosomal vesicle.  
In the cap phase the acrosomal vesicle move towards the anterior pole of the 
nucleus. The acrosomal vesicle grows and forms the head cap that covers approximately 
the anterior two thirds of the nucleus. The two centrioles assemble at the caudal pole of the 
nucleus, and the distal centriole gives rise to the outgrowing flagellum within the tail.  
In the acrosomal phase the nucleus and cell body start to elongate in a craniocaudal 
direction. At the same time, the nucleus starts chromatid condensation and moves toward 
the cranial end, leaving the other organelles behind. In the mean time, the spermatids rotate 
so that the nucleus is directed toward the tubular periphery and the developing tail toward 
the lumen. 
In the maturation phase nuclear condensation is completed and most of the 
mitochondria gather around the axoneme in a helicoidal manner within the region 
corresponding to the future middle piece of the spermatozoon. Outer fibers and the fibrous 
sheath of the future principal piece develop. The volume of a spermatid in late maturation 
phase amounts to only 20 to 30% of that of cap phase spermatid. After completion of the 
development of the tail, the residual body is separated from the spermatozoon and the 
intercellular bridges (IB) between the germ cells are now interrupted (Leblond and 
Clermont 1952b; Russell et al., 1990). 
2.2.3.3 Spermatogenic cycle, stage and wave  
Examination of serial cross-sections of a seminiferous tubule revealed that sperm 
cells differentiate in distinctive associations (Leblond and Clermont 1952a, Swierstra 
1968a, b, Clermont 1972, Parvinen et al., 1986, Hess 1990, Russell 1993b). It is this 
unique association of germ cells with Sertoli cells that constitutes the cycle of the 
seminiferous epithelium, and each particular association of germ cells is referred to as a 
stage (Leblond and Clermont 1952a, Hess et al., 1990, Parvinen 1993). A spermatogenic 
cycle is defined as the time it takes for the reappearance of the same stage within a given 
segment of the tubule (Clermont 1972, Parvinen et al., 1986). Each stage of the cycle 
LITERATURE REVIEW 
   
30 
follows in an orderly sequence along the length of the tubule and the distance between the 
same stages is called the spermatogenic wave (Perey et al., 1961). One tubule can contain 
numerous complete waves. Adjacent segments of the tubule communicate in some 
unknown manner. The number of stages in a particular species is thus defined as the 
number of morphologically recognizable germ cell associations within the testis. The 
number of stages within a spermatogenic cycle and the number of cycles required for the 
completion of spermatogenesis varies between species (Table 1) (Clermont 1972; Hess 
1990; Onyango et al., 2000). 
Table 1: Length (days) of cycle, duration of spermatogenesis and of stages of 
seminiferous cycle epithelium in various species 
Stage I II III IV V VI VII VIII Cycle Spermatogenesis 
Boar 1.1 1.4 0.4 1.2 0.8 1.6 1.0 0.8 8.3 39 
Bull 4.2 1.2 2.7 1.7 0.2 0.8 1.1 1.6 13.5 61 
Dog 2.6 1.3 0.8 1.8 0.7 1.2 0.7 1.0 10.4 48 
Goat 1.7 1.4 2.2 1.1 1.2 1.0 0.8 1.2 10.6 47.7 
Rabbit 3.1 1.5 0.8 1.2 0.5 1.7 1.3 0.9 11.0 48 
Ram 2.2 1.1 1.9 1.1 0.4 1.3 1.1 1.0 10.1 47 
Stallion 2.0 1.8 0.4 1.9 0.9 1.7 1.6 1.9 12.2 55 
2.2.3.4 Stages of spermatogenesis in the boar  
In the boar a seminiferous cycle of 8.3 days is comprised of 8 developmental stages 
(Fig. 7) (Swierstra 1968a). In this species approximately 4.5 cycles occur before a type A1 
spermatogonium is transformed into a spermatozoon and thus, the entire process of 
spermatogenesis takes about 39 days. The seminiferous cycle begins with the 
accomplishment of spermiation (stage 1) and ends with apical migration and close 
attachment of late maturation phase spermatids at the Sertoli cell apex, separated from their 
residual bodies ready for spermiation (stage 8) (Fig. 5I-VIII) (Swierstra 1968 a, b). The 8 
stages can grossly be divided into three phases (Hess 1990, Kohler 2004, Mutembei 
2005b), Phase I seen immediately after spermiation and characterised by absence of 
elongated spermatids; corresponds to stage 1, Phase II seen during spermatid elongation 
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and characterised by presence of elongating spermatids at various stages of maturation; 
corresponds to any of stages 2-6 and Phase III seen prior to spermiation and characterised 
by presence of fully elongated spermatids; corresponds to any of stages 7-8. 
 
Fig. 5: Stages of spermatogenesis in the boar. A0-3 = Type A spermatogonia, In = Intermediate 
spermatogonia, B = Type B spermatogonia, Le = Leptotenes, Z = Zygotenes, P = Pachytenes, R = Round 
spermatids, el = elongated spermatids, M = mitosis, M1, M2 = meiosis 1 and meiosis II (Swierstra 1968 a). 
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Fig. 5I: Stage 1 of spermatogenesis. Following spermiation, round spermatids (RS) lie nearest the 
lumen, followed basally by two generations of primary spermatocytes, i.e., old pachytenes   (P) and 
young leptotenes (L). This stage is characterised by lack of any elongating/ed spermatids (Swierstra 
1968 a). 
 
Fig. 5II: Stage 2 of spermatogenesis. This stage is characterised by spermatids whose dark 
staining nuclei are beginning elongation (ES). The two generations of primary spermatocytes are 
old pachytenes (P) and young zygotenes (Z), which were the leptotenes in the previous stage 
(Swierstra 1968 a). 
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Fig. 5III: Stage 3 of spermatogenesis.  This stage is characterised by elongating spermatids (ES) 
that are arranged in bundles and lying in deep apical recesses of the Sertoli cell close to its nucleus. 
The zygotene (Z) and pachytene (P) primary spermatocytes are arranged near the basal membrane 
(Swierstra 1968 a). 
 
Fig. 5IV: Stage 4 of spermatogenesis. This stage is characterised by presence of the two meiotic 
divisions of spermatogenesis - the first and/or second meiotic divisions take place in this stage. In 
addition to bundles of maturing elongating spermatids (ES) and zygotene primary spermatocytes 
(Z) either diplotene secondary spermatocytes (D / II) or round spermatids are seen (Swierstra 1968 
a). 
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Fig. 5V: Stage 5 of spermatogenesis. This stage is characterised by presence of two generations of 
spermatids, older elongating spermatids (ES) and newly formed round spermatids (NS). The 
zygotene primary spermatocytes of stage 4 enter the pachytene (P/Z) stage and leave their basal 
position (Swierstra 1968 a). 
 
Fig. 5VI: Stage 6 of spermatogenesis. This stage is characterised by presence of the bundles of 
older elongated spermatids (ES) having moved away from the vicinity of the Sertoli cell nuclei 
with their tails projecting into the lumen of the tubules. In addition to round spermatids (RS) 
pachytene primary spermatocytes (P) and spermatogonia (SG) lie near the basal lamina (Swierstra 
1968 a). 
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Fig. 5VII: Stage 7 of spermatogenesis. This stage is characterised by presence of elongated 
spermatids (ES) at the maturation phase – here spermatids continue to migrate centrally but are still 
not separated from their residue body. The spermatogonia divide to form preleptotene primary 
spermatocytes (PL). Also observed are pachytene primary spermatocytes (P) and round spermatids 
(RS) (Swierstra 1968 a). 
 
Fig. 5VIII: Stage 8 of spermatogenesis. In this stage the spermatozoa leave the tubular epithelium 
following separation from their residual bodies (RB). Remaining in the epithelium are round 
spermatids (RS) and two generations of primary spermatocytes (older pachytenes (P) and young 
preleptotene (PL) (Swierstra 1968 a). 
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2.2.3.5 Sperm release (spermiation) and maturation 
Spermiation is a process by which spermatozoa are released from the seminiferous 
epithelium into the lumen of the tubule (Russel 1993b), leaving behind residual bodies that 
they discarded within the seminiferous epithelium (Russell 1993c). A small amount of 
cytoplasmic material (cytoplasmic droplet) remains attached within the neck region or 
around the middle piece as the spermatozoon makes its way into the epididymis via the 
excurrent duct system, the rete testis and the efferent ducts. Seminiferous spermatozoa lack 
motility and hence fertilizing capacity. During transit through the epididymis, which takes 
approximately two weeks (about 9 to 14 days in boar) (Swierstra 1968b; Frankenhuis et al., 
1982), the spermatozoa undergo a series of biochemical changes to become motile and 
capable of fertilization (Clermont 1972, Hess 1990, Hess et al., 1997). The cytoplasmic 
droplet migrates distally along the tail of the spermatozoon and falls off. This event is 
correlated with an increase in motility, up to 60-70%. 
2.2.3.6 Rate of sperm production in the boar  
Daily sperm production per gram of testis in the boar is 20 to 30 106 (Amann 
1970, Frankenhuis et al., 1982, Trudeau and Sanford 1986). Sperm production increases 
with age in the post-pubertal period and it is not markedly affected by season of the year 
(Trudeau and Sanford 1986, Cameron 1997). 
2.3 Neuroendocrine regulation of spermatogenesis  
2.3.1 Sertoli-Germ cell interaction 
Germ cell development relies on a highly coordinated interaction with the Sertoli 
cell; communication is via ligand/receptor-mediated interactions or paracrine factors. The 
production and secretion of many Sertoli cell proteins involved in germ cell development 
occur in a stage-dependent manner (Parvinen 1982). Although Sertoli cell signalling is the 
major controlling factor in the timing of germ cell development, also germ cells have an 
immediate input as was shown in experiments when rat germ cells being in contact with 
mouse Sertoli cells developed according to the kinetics of rat and not of the mouse 
spermatogenesis (Franca et al., 1998). Important factors that control Sertoli cell function 
are testis derived and anterior pituitary gland hormones. 
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2.3.2 LH, FSH, Testosterone 
LH targets the Leydig cell to stimulate the secretion of testosterone, which in turn 
acts on androgen receptors in the Sertoli cells and peritubular myoid cells of the 
seminiferous epithelium to control spermatogenesis (Weinbauer and Nieschlag 1993, 
Sharpe 1994, McLachlan et al., 1996). Androgen-binding protein sequesters testosterone 
within the seminiferous tubule to ensure it is maintained at adequate effective levels. FSH 
targets receptors within the Sertoli cell, possibly inducing a multitude of responses. Well 
established is the secretion of inhibin and activin, which respectively inhibit or promote the 
release of FSH (Weinbauer and Nieschlag 1993, Sharpe 1994, McLachlan et al., 1996). 
The roles of testosterone and FSH in spermatogenesis have been studied 
extensively. FSH (Dunkel et al., 1997b) as well as androgens (Erkkilä et al., 1997) act as 
germ cell survival factors but androgens alone have been shown to stimulate all phases of 
germ cell development in the hypogonadal (hpg) mouse, which is congenitally deficient in 
GnRH and hence LH and FSH (Singh et al., 1995). 
FSH is essential for quantitatively normal spermatogenesis and fertility. Thus in 
transgenic male mice with a targeted disruption of the FSH receptor gene (Dierich et al., 
1998) or of the FSH b-subunit gene (Kumar et al., 1997), though being fertile and 
displaying all stages of germ cell development (Singh et al., 1995), the testes are smaller 
and produced less spermatozoa (Singh et al., 1995, Dierich et al., 1998, Kumar et al., 
1997). FSH receptor knockout mice also demonstrate defects in sperm development that 
lead to the production of low quality ejaculates (Krishnamurthy et al., 2000). These 
findings in the mouse are almost identical with those in human males exhibiting a mutation 
related to inactivation of the FSH receptor (Tapanainen et al., 1998). These observations 
underline the importance of FSH during the neonatal and postnatal period for testicular 
development and maintenance of quantitative normal spermatogenesis (Singh and 
Handelsman 1996a, b). It is also involved in fluid absorption/secretion (Jeguo et al., 1982). 
2.3.3 Estrogens 
In many papers estrogens and compounds exhibiting a partial estrogenic activity are 
described as negatively interfering with spermatogenesis and testicular function in general. 
Thus estrogen administration to experimental animals during the neonatal period or 
adulthood can impair sperm production and maturation (Steinberger and Duckett 1965, 
Meistrich et al., 1975) and there are various reports that exposure to estrogens in the 
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environment might have a detrimental effect on male reproductive development and health, 
and may be related to the reported decreases in sperm counts in men over the past 50 years 
(Auger et al., 1995, Sharpe and Skakkebaek 1993, Toppari et al., 1996, Sharpe 1997). 
Along this line Abney (1999) could show that neonatal estrogen exposure can interfere 
with Leydig cell development and proliferation during puberty. Ethane dimethansulfonate 
(EDS) has been shown to cause destruction of Leydig cells by blocking their regeneration 
(Abney and Myers 1991). However, a physiological role of estrogens in the male and 
hence also in testicular function is suggested by their production in the Leydig cell as was 
demonstrated for the boar (Claus and Hoffmann 1980; Conley et al., 1996, Fraczek et al., 
2000, Rostalski et al., 2000; Mutembei et al., 2005b). Estrogen appears to inhibit 
proliferation of precursor and adult-type Leydig cells during pubertal development, a 
process important for the establishment of the adult complement of Leydig cells (Nistal et 
al., 1986, Hardy et al., 1991, Habert et al., 2001); they may therefore be important in 
controlling the steroidogenic capacity of the adult testis. 
In granulosa cells of the ovary, estrogens induced the formation of transforming 
growth factor  (TGF), which in turn stimulated DNA synthesis; from these observations, 
Dorrington et al. (1993) concluded that in somatic cells of the gonads, FSH may induce 
aromatase activity and hence estrogen production, which in turn stimulates TGF, which 
then, along with FSH, promotes granulosa cell division. The fact that similar control 
mechanisms exist in Sertoli cells led to the hypothesis that prior to puberty estrogen may 
also participate in the FSH-mediated mitogenic activity on Sertoli cells via induction of 
TGF (Dorrington and Khan 1993, Dorrington et al., 1993). 
Estrogens have also been suggested to stimulate postnatal spermatogonial division 
in the mouse (Li et al., 1997, Miura et al., 1999), they influence Sertoli cell maturation 
during the post proliferative period (Sharpe et al., 1998), where they have been shown  to 
have a role in regulating the expression of the cell adhesion molecule neural cadherin 
(NCad) (MacCalman and Blaschuk 1994a, b) in cultured mouse Sertoli cells (MacCalman 
et al., 1997). Given that NCad is important for cell-cell interactions in the testis, 
particularly between germ cells and Sertoli cells (Perryman et al., 1996, Newton et al., 
1993), this may be one way in which estrogens are involved in establishing and 
maintaining the seminiferous epithelium. There are also recent evidences for a direct role 
for estrogen in promoting survival and mitosis of germ cells. Estradiol implants in 
hypogonadal (hpg) mouse stimulated a 4-5-fold increase in seminiferous tubular volume in 
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the absence of measurable levels of androgens (Ebling et al., 2000) and treatment of boars 
actively immunised against GnRH with estrogen restarted up to 60% of the arrested 
spermatogenesis (Wagner and Claus 2004). Furthermore low concentrations of 17-
estradiol effectively inhibited male germ apoptosis, which was induced in vitro by 
incubating segments of human seminiferous tubules without survival factors (i.e., serum 
and hormones) (Pentikainen et al., 2000). Also round spermatid apoptosis was increased in 
the seminiferous tubules of older aromatase (Ar) KO mice (Robertson et al., 1999, 2002), 
also pointing to a role for estrogen in acting as a spermatid survival factor. Moreover adult 
monkeys treated with an aromatase inhibitor showed a decrease in the conversion of round 
to elongated spermatids and a decrease in sperm output from the testis, which suggests that 
estrogens are also important for spermatid differentiation (Shetty et al., 1997, 1998). 
Additionally the observation made in ArKO mice that round spermatids, that did not 
undergo apoptosis early in spermiogenesis, had acrosomal dysgenesis (Robertson et al., 
1999) suggests that acrosome biogenesis could be an estrogen-dependent process. 
The stimulatory effect of estrogens on spermatogenesis was also investigated by the 
administration of estradiol to hpg mice (Ebling et al., 2000), which lack FSH and LH due 
to a congenital deficiency of GnRH. The testes of these males were underdeveloped with 
spermatogenesis arrested at the early stages of germ cell development; however after 
administration of estradiol (SILASTIC implants) for a period of 70 days, their testes 
showed all stages of spermatogenic cell development (Ebling et al., 2000). This together 
with the fact that treating actively GnRH immunized boars with estrogen leads to a 60% 
restoration of the arrested spermatogenesis (Claus and Wagner 2004) strongly suggest that 
estrogens are capable of inducing spermatogenesis. 
Although the above studies suggest a role for estrogen in germ cell development, it 
has been pointed out that the administration of a dual ERα/ERβ antagonist ICI 182,780 to 
wild-type mice for 35 days did not produce observable changes in the morphology of the 
seminiferous epithelium apart from the expected distension of the rete testis (Lee et al., 
2000). However, the ability of the ICI antagonist to cross the blood-testis barrier and enter 
the adluminal compartment of the seminiferous epithelium to locally block estrogen action 
has not been demonstrated, nor has the ability of the antagonist to fully block the high 
levels of estrogen that may be present in the testis. Again, the possibility of other variant 
forms of ER taking over the roles of the classical ERs in the knockout models have not 
been eliminated (Scobie et al., 2002), which warrants further studies. 
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2.4 Steroid hormones and their mechanisms of actions 
2.4.1 Overview on steroid hormones 
Steroid hormones are a class of signalling molecules that are synthesized in 
response to a variety of neuroendocrine activities for a wide range of functions. All steroid 
hormones are derivatives of cholesterol and hence share the same basic ring structure, the 
cyclopentanoperhydrophenanthrene nucleus. According to the number of carbon-atoms 
and function, steroid hormones are divided into various classes (Table 2) (Schulster et al., 
1976; Duke et al., 1995). 
Table 2: Sources and functions of the main steroids 
Steroid Source Main function 
Estrogens (C18-steroids) Adrenal cortex and gonads Primarily involved in 
female sexual determination 
Androgens (C19-steroids) Adrenal cortex and gonads Male sexual determination 
Progestins (C21-steroids)  Ovaries and placenta Maintains pregnancy 
Glucocorticoids (C21) Adrenal cortex Gluconeogeneis, Decrease 
inflammation and  increase 
resistance to stress 
Mineralocorticiods (C21)  Adrenal cortex Maintain salt and water 
balance 
About 95% of the steroid hormone (SH) in blood is bound to plasma transport 
proteins and a sex steroid-binding protein (SBP), also known as sex hormone binding 
globulin (SHBG). SHBG specifically binds dihydrotestosterone (DHT), testosterone (T), 
and 17-estradiol (E2) in plasma and hence contributes to the control of their metabolic 
clearance rates (Duke et al., 1995). 
Until recently a conventional dogma held that protein–bound steroid hormones are 
inactive and that only free forms traverse cell membranes passively, owing to their 
lipophilic nature. However it has been demonstrated that megalin, a low density lipoprotein 
(LDL), functions as an endocytotic receptor in reproductive tissues (Petersen et al., 2002). 
Megalin provides a pathway for cellular uptake across the plasma membrane of androgens 
and estrogens bound to SHBG by forming a ternary complex with the steroid, the SHBG-
complex (Hammes et al., 2005). The complex is thought either to endocytose the hormone 
into the cell, or to accelerate its diffusion by concentrating it onto the cell surface. In 
addition the ternary E2/SBP/SBP-receptor complex may function in signal transduction. In 
megalin receptor knockout mice, males had impaired descent of the testes and females had 
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blockade of vaginal opening, both of which critically dependent on sex-steroid signalling; 
similar defects are seen in animals treated with androgen- or estrogen-receptor antagonists. 
Regardless of the type of steroid hormone, all act via membrane-bound and/ or 
nuclear receptors through a similar mechanism, with both genomic and non-genomic 
effects that interrelate. Their non-genomic functions are rapidly exhibited and are achieved 
via membrane-bound receptors through activation of second messengers, notably the 
mitogen-activated kinase signalling pathway (Aronica et al., 1994, Wehling 1997, 
Boldyreff and Wehling 2003). A steroid effect that occurs between a few seconds and 1–2 
min after steroid application is likely due to a non-genomic rather than a genomic effect 
(Wehling 1997). Non-genomic responses e.g. glucose uptake, monovalent and divalent 
cation transport, water imbibitions, increased discharging activities of the secretory 
vesicles and rapid changes in electrical activity of neurones can not be blocked by 
inhibitors of DNA transcription or protein synthesis (e.g. actinomycin D or 
cycloheximide). 
However the principal functions of steroids are through genomic activities achieved 
through nuclear receptors. Although genomic actions of steroids e.g. cell division 
(proliferation), cell growth and tissue development are much slower than the non-genomic 
responses, they are responsible for the prolonged synthetic effects. Though even more 
rapid effects of steroids on transcriptional processes are known, most actinomycin D– or 
cycloheximide-sensitive actions occur after a lag phase of 10 min or more. The additional 
delay at the effector level is probably the result of the time required for the processing of 
newly synthesized protein molecules (Wehling 1997). Hence a typical steroid hormone 
response has been described as the modulation of nuclear transcription, thus triggering 
genomic events that are responsible for physiological effects (Hendry et al., 1977, Hendry 
1988, Rollerova and Urbancikova 2000). 
Steroid-bound nuclear receptors act either at target genes that contain classical 
steroid responsive elements within their promoter regions or regulate transcription at 
promoter elements that directly bind heterologous transcription factors (Kushner et al., 
2003), such  as the AP1 (activated protein-1) sites and the variant cyclic-AMP responsive 
elements (CRE) which bind Jun/Fos- and c-Jun/ATF-2 transcription factors respectively. 
Nuclear steroid receptors are usually intranuclear but the unbound receptors shuttle 
between the nucleus and the cytoplasm (Schwabe et al., 1993). A cell’s ability to respond 
to a particular steroid hormone is based on the presence or absence of the specific steroid 
receptors. 
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2.4.2 Steroid hormone receptors and induction of transcription 
Steroid receptors are grouped into a large nuclear receptor superfamily, which 
evolutionally, might be derived from one ancestor. The three-dimensional structures of 
many nuclear receptor ligand binding domains (LBD) and of various ligand complexes 
have been determined and have provided an understanding of the structural basis of 
selectivity and mode of action of receptor agonists and antagonists (Gronemeyer et al., 
2004). It is frequently the case that several paralogous genes that originated by gene 
duplications characteristic of the vertebrate lineage encode the receptor for a given ligand. 
This multiplicity of nuclear receptors is an important factor that contributes to both signal 
diversification and specification. However, whereas paralogue-selective ligands have been 
synthesized, it is not known whether endogenous ligands with such selectivities are 
operative in vivo (Gustafsson 2003). 
Steroid receptors are a family of similar proteins with a six functional domain 
structure (Fig.6a) (O'Malley et al., 1991). 
 
Fig. 6a: Schematic illustration of the structural and functional organisation of nuclear receptors. 
The evolutionarily conserved regions C and E are indicated as boxes (green and orange, respectively), and a 
black bar represents the divergent regions A/B on the N-teminal, D and Fon the C-terminal. Domain 
functions are depicted above and below the scheme. AD, activation domain; AF1, activation function 1; NLS, 
nuclear localization signal (Gronemeyer et al., 2004). 
The N-terminal A/B domain contains transactivation function AF-1, which 
activates target genes by interacting with components of the core transcription machinery 
(Horwitz et al., 1996, Katzenellenbogen and Katzenellenbogen 2000). 
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Fig. 6b: Structure of ER DNA binding domain (DBD) P box - transcription control region, D box - dimer 
specificity control region, CTE – COOH-terminal extension (Dechering et al., 2000). 
The hydrophilic C domain is the DNA binding domain (DBD), which is highly 
conserved and contains two type II zinc-binding motifs that span 60-70 amino acids with a 
COOH-terminal extension (CTE). Each zinc ion is tetrahedrally liganded by four 
conserved cystein ligands forming a finger-like shape within the steroid receptor, hence the 
so-called first- and the second fingers of the receptor. The first finger (P box) controls the 
specificity of DNA binding while the second (D box) controls specificity of dimerization 
(Fig.6b) (Schwabe et al., 1993). The hinge or hyper variable D region allows the receptor 
protein to bend or alter its conformation (Tsai and O’Malley 1994). 
The relatively large C-terminal E domain contains the ligand-binding domain 
(LBD) that determines ligand specificity (Mueller-Fahrnow and Egner 1999). Additionally, 
this domain harbours regions that allow the receptor to dimerize. The LBD contains 12 -
helices and two -sheets, which are secondary structural elements, arranged in a so-called 
the -helical sandwich-protein fold (Rollerova and Urbancikova 2000). The F domain in 
ER contains 42 amino acids, is not well conserved among different species and is 
concerned with transcription (Dechering et al., 2000). 
Binding of a ligand to a nuclear receptor causes a series of downstream events, 
including receptor dimerization, receptor-DNA interactions mediated by SREs (steroid 
responsive elements) present in the promoter regions of the target genes, recruitment of 
and interactions with transcription factors, and formation of a preinitiation complex that 
ultimately causes changes in target gene expression (Fig. 6c). Unbound receptors are 
normally associated with chaperone proteins such as heat shock protein 70 and 90, which 
get dissociated after the receptor binds to its ligand. Transcription itself is affected by a 
number of factors, some receptor and cell-specific, and others harboured within the 
receptor. The receptor C-terminal domain contains AF-2 interacting surface that mediates 
ligand binding and dimerization to stimulate transcription activity and the N-terminal 
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domain encodes an activation function called AF-1 that mediates protein-protein 
interaction to induce transcription (Dechering et al., 2000, Gronemeyer et al., 2004). 
 
Fig. 6c: Steroid hormone-receptor interaction (Gronemeyer et al., 2004) 
In the absence of the ligand, several of the nuclear receptors are believed either to 
be bound to the regulatory regions of target genes as a corepressor or associated with a 
histone deacetylase (HDAC) complex as apo receptors. Histone deacetylation causes 
chromatin condensation that accounts for the gene-silencing effect of apo receptors. Ligand 
binding releases the HDAC complex from the apo receptors and results in the recruitment 
of histone acetyltransferase (HAT) and chromatin-remodelling complex, a process that 
occurs in a receptor-, target-gene- and cell-specific manner. This process allows the 
polymerase II holoenzyme complex, comprising of the polymerase II enzyme, TATA-
binding protein-associated factor (TAF) and other mediators to be recruited to initiate 
transcription. Then the activated genes create new mRNA that moves back into the 
cytoplasm and gets translated into new proteins for the required cellular processes. Also, 
the ligand can also interact with its cognate receptor within the cytoplasm where it can 
exert a ‘non-genomic effect’ by interacting either directly, for example, with membrane 
receptors that activate kinases or use second messengers to effect rapid non synthetic 
responses (Robyr et al., 2000, Dechering et a., 2000, Kushner et al., 2003, Gronemeyer et 
al., 2004). 
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2.4.3 Testicular steroid hormone synthesis 
Cholesterol is the common precursor during steroidogenesis (Fig. 7) and it is 
initially converted to pregnenolone by CYP 450-SCC side chain cleavage enzyme. 
 
Fig. 7 Synthetic pathway of testicular steroid hormones P450 Scc –cytochrome P450 side chain 
cleave, P50c 17  - Cytochrome P450c 17 hydroxylase, 3-HSD - 3-hydroxy steroid dehydrogenase, 17-
HSD - 17-hydroxysteroid dehydrogenase, P450arom – Cytochrome P450 aromatase. 
The conversion of cholesterol to pregnenolone by the CYP 450-SCC enzyme, 
which is present on the inner mitochondrial membrane, is the rate-limiting step in steroid 
production (Gill 1995). Following the ∆ 4-pathway pregnenolone may be converted to 
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progesterone by 3-hydroxysteroid dehydrogenase (3 HSD) or via the ∆ 5-pathway into 
17-OH-pregnenolone and dehydroepiandrosterone (DHEA) by the activity of 17-
hydroxysteroid dehydrogenase and C17,20-lyase. Both pathways lead to the formation of 
the C19-steroids androstenedione and testosterone. 
Synthesis of estrogen occurs through conversion of the C19 steroids like 
androstenedione and testosterone to estrone (E1) and estradiol (E2), respectively. A 
microsomal member of the cytochrome P450 super family, the cytochrome P450 
aromatase (P450 arom), which is a product of the CYP19 gene, catalyse this conversion. 
P450 arom is widely expressed in the testis across species (Oh and Robinson 1993, 
Simpson et al., 1997). The particular steroid hormone that a given tissue produces depends 
upon the nature of the tissue and the activity of the enzymes present in that tissue. 
A special pathway involved in the regulation of estrogen bioavailability involves 
two enzymes, StS and EST. Sulfatase (StS) is an enzyme that is a product of the StS-gene 
located on the short arm of the X-chromosome (Yen et al., 1987). This enzyme is primarily 
localised to the endoplasmic reticulum (Chang et al., 1986). It catalyses removal of the 
sulfate group from 3- hydroxysteroid sulfates, such as cholesterol-3-sulfate, 
dehydroepiandrosterone-3-sulfate (DHEAS) and estrone-3-sulfate (Purohit et al., 1994). 
StS is expressed in various tissues, including in the testis (Munroe and Chang 1987) and 
placenta of the mouse (Shankaran et al., 1991), bovine (Greven et al., 2006) and human 
breast cells (Chandra 2003). Also in vitro studies with boar testicular tissue have 
demonstrated activity of this enzyme (Rostalski 2005). The presence of StS in the testis of 
various species may be suggestive of its involvement in the provision of free steroids. 
Steroid sulfotransferases, which are cytosolic enzymes, reduce the bioavailability of 
free estrogens by catalysing the sulfonation of steroids (Hobkirk 1993, Strott 1997). 
Although their expression in the liver of animals and man has been assumed to play a role 
in maintaining steroid hormone homeostasis (Hobkirk 1985, Chatterjee et al., 1994), little 
was known about the structural and catalytic properties of the individual enzymes involved 
until molecular cloning studies and characterization of expressed enzymes yielded insights 
regarding their evolution and potential physiological roles (Hobkirk 1993, Weinshilboum 
et al., 1997). This led to identification of an estrogen-specific sulfotransferase (EST), 
which was shown to be evolutionarily distinct from steroid sulfotransferases that 
preferentially metabolize non phenolic hydroxysteroids (Weinshilboum et al., 1997, Nash 
et al., 1988, Oeda et al., 1992, Song et al., 1995). 
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The sequence of EST was found to have a higher degree of homology with the 
family of phenol sulfotransferases than with the hydroxysteroid sulfotransferases (Hobkirk 
1993, Weinshilboum et al., 1997). In addition, functional characterization of 
heterologously expressed EST protein demonstrated that it catalyzes the specific 
sulfonation of estrogen (estradiol, estrone, and estriol) with Km values in the low 
nanomolar range (Song et al. 1995, Falany et al., 1995). These observations provided good 
evidence for a specific role for EST in modulating the activities of estrogens in vivo. Thus, 
EST can be defined as a cytosolic enzyme that catalyzes the specific sulfonation of 
estrogens at the 3-hydroxyl position using 3'-phosphoadenosine-5'-phosphosulfate as an 
activated sulfate donor. Sulfated estrogens are hormonally inactive and no longer bind to 
the estrogen receptor. 
Although the liver has been considered a primary site for steroid sulfotransferase 
activities, significant activities have also been found in other organs, e.g. the bovine 
placenta (Moore et al., 1988; Hoffman et al., 2001). EST is also expressed abundantly in 
the testis of rat and man (Song et al., 1995), suggesting that testicular expression of EST 
may be a common phenomenon among different species. In the boar, Reaside (1983) 
reported conjugation of estrogens within cultured Leydig cells and Rostalski et al. (2000) 
reported some activities of EST in testicular tissue homogenates. In the mouse testis, EST 
was localized selectively to the Leydig cells, with its expression being under the control of 
LH and regulated differentially during development (Song et al., 1997). Together, this 
information seem to suggest that testicular expression of EST may play a role in male 
reproduction, conceivably by modulating the activity of locally synthesized estrogens in 
the testis. 
Steroids can also be conjugated with glucuronic acid by the enzyme glucuronyl 
transferase. This reaction takes place in the liver and uridine diphosphoglucuronic acid is 
the glucuronide donor. Like sulfonation glucuronidation makes the steroid more water-
soluble and is also a process of their inactivation for excretion. Another important factor 
regulating steroid hormone activity is peripheral conversion, for example reduction of 
testosterone via 5-reductase to dihydrotestosterone, producing a more potent form of 
testosterone (for review see O’Malley et al. 1991). 
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2.5 Estrogen receptors (ERs) and their expression in the testis and epididymis 
Estrogen receptors exist in two isoforms, the ER and ER, which originate from 
two separate genes on different chromosomes. 
As indicated in Fig. 8 the two isoforms are highly homologous in their DNA 
binding domain (over 90%) while homogeneity in their ligand-binding domain is less than 
60% (Cowley et al., 1997). They exhibit a similar affinity for estradiol-17 but not for 
other ligands and form homo- and heterodimers (Muramatsu and Inoue 2000), allowing 
them to act as selective estrogen receptor modulators (SERMs) (Riggs and Hartmann 
2003). 
 
Fig. 8: Comparison of the structure of ER and ERβ proteins. The functional domains A–F and the 
percentage homology of ERβ compared with ER are shown. Indicated are the N-terminal domain (A/B 
domain), the DNA binding domain (DBD) (C domain), the hinge region (D domain), the ligand-binding 
domain (E domain), and the C-terminal region (F domain). The two potential start sites on ERβ are 
designated -53 and +1 (O'Donnell et al., 1991). 
More recently it has become clear that estrogen signalling can be viewed as a 
balancing act between ERα and ERβ (Weihua et al., 2000, Lindberg et al., 2003, 
Gronemeyer et al., 2004); ERα is often an activating factor, whereas ERβ suppresses 
and/or modulates the effects of ERα. For instance, estradiol-17β-activated ERα stimulates 
the proliferation of MCF-7 breast cancer cells, whereas ligand-activated ERβ acts as an 
antiproliferative factor and prevents the effects of ERα. The antiproliferative effects of 
ERβ are also seen in colon and prostate cancer cells (Gustafsson 2003). 
Both, the ER and ER, are widely distributed in the epididymis of the male 
reproductive tract (Echeverria et al., 1994, Hess et al., 1997, 2001, Carreau et al., 1999, 
2003, O` Donnell et al., 2001, Hess 2003, Carpino et al., 2004, Hess and Carnes 2004). 
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They are also expressed in the testis as was shown for the human (Enmark et al., 1997, 
Durkee et al., 1998, Pelletier and El-Alfy 2000, Pentakainen et al., 2000, Taylor and Al-
Azzawi 2000, Takeyama et al., 2001, Saunders et al., 2002), monkey (West and Brenner 
1990, Fisher et al., 1997, Saunders et al., 2001), goat (Goyal et al., 1997), dog and cat (Nie 
et al., 2002), rat and mouse (Lubahn et al., 1993, Saunders et al., 1998, Zhou et al., 2002, 
Oliveira et al., 2004). 
In the testis, ERβ is the more abundant receptor and is typically found in nearly 
every cell type of the interstitium and the seminiferous tubule, except for the elongated 
spermatids (Table 3) (Saunders et al., 1997, 1998, Rosenfeld et al., 1998, van Pelt et al., 
1999, Bilinska et al., 2000, 2001, Jefferson et al., 2000, Pelletier 2000, Pentikainen et al., 
2000, Taylor and Al-Azzawi 2000, Makinen et al., 2001, McKinnell et al., 2001, Saunders 
et al., 2001, Takeyama et al., 2001, Nie et al., 2002, Zhou et al., 2002). 
Table 3: Localization of ER and ER in the testis and epididymis in various species 
Cell type Rat Mouse Dog Cat Man 
Leydig      -/+ 
Sertoli  , -/+  -  - 
Germ cells , -/+ , -/+ -   
Peritubular   -/+, -/+   - 
Rete testis     - 
Efferent ductus      
epididymis     - 
-/+ means some authors detected presence of the receptors while others reported otherwise 
LITERATURE REVIEW 
   
50 
The ERα has been identified in the interstitium of the testis of the rat, mouse dog, 
cat and human (see in Table 3) (Iguchi et al., 1991, Echeverria et al. 1994, Fisher et al., 
1997, Pelletier and El-Alfy 2000, Pentikainen et al., 2000, Nie et al., 2002, Zhou et al. 
2002) but it is not apparently expressed in the Leydig and peritubular myoid cells of the 
testis of the goat, monkey and human (West and Brenner 1990, Goyal et al., 1997, 
Saunders et al., 2001). ER has also been localised in germ cells of the rat (Lubahn et al., 
1993, Saunders et al., 1998, Oliveira et al., 2004), mouse (Bilinska et al., 2001, Zhou et al., 
2002, Sipila et al., 2004), and vole (Bilinska et al., 2001), but not of the dog and cat (Nie et 
al., 2002, Zhou et al., 2002). 
2.6 Functions of estrogen in the epididymis and testis 
Estrogens are involved directly in regulating epididymal fluid reabsorption (Hess 
1990), a process not only indirectly affecting testicular function but also essential for 
maintenance of normal fertility (Lubahn et al., 1993, Korach 1994, Hess et al., 1997, 
2000). However, the direct roles for estrogens in testicular cells still need further 
clarification. 
It is well established that administration of estrogens during the neonatal period or 
adulthood impairs sperm production and maturation (Steinberger and Duckett 1965, 
McLachlan et al., 1975a, b, Stillman 1982, Raman-Wilms et al., 1995, Cheek and 
McLachlan 1998, Toppari et al., 1996, Toppari and Skakkebaek 1998, Vom Saal et al., 
1998, Akingbemi and Hardy 2001, Norgil Damgaard et al., 2002), indicating that estrogens 
have the ability to perturb spermatogenesis. More so, loss of estrogen synthesis in the 
aromatase knockout mouse (O’Donnell et al., 2001, Robertson et al. 2002) resulted in 
decreased fertility with age due to lesions associated with round spermatids and decreased 
volume and length of the seminiferous tubule. These effects were accelerated and 
enhanced when the ArKO male was maintained on a soy-free diet, suggesting soy based 
phytoestrogens likely protected the testis somewhat in the ArKO mouse. Testosterone 
concentrations are elevated in the ERKO male (Eddy et al., 1996) and estrogens seem to 
have a subtle effect on Leydig cell function because pure ER inhibitor ICI 182,780 on them 
showed increased steroidogenesis (Akingbemi et al. 2003). ER has been shown to 
support somatic cells and spermatogenesis (Mahato et al., 2002). 
Other studies with mice evidence in developing testis have revealed that estradiol 
has a significant activity in initiating gonocyte mitosis, establishing Sertoli cell function 
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(O’Donnell et al., 2001), inhibiting germ cell apoptosis (Pentikainen et al., 2000) and 
establishing Sertoli-germ cell adhesion (MacCalman and Blaschuk 1994b, MacCalman et 
al., 1997). In vitro models have also provided evidence that 17-estradiol can induce 
neonatal testicular gonocyte and spermatogonia proliferation (Li et al., 1997, Miura et al., 
1999). A stimulatory effect of a 4 to 5-fold increase in seminiferous tubular volume in 
estradiol-implanted hpg mice (Ebling et al., 2000) and a restoration of up to 60% of 
previously arrested spermatogenesis in estrogen-treated boars actively immunised against 
GnRH (Wagner and Claus 2004) proved that estrogens influence spermatogenesis. In the 
boar this effect could be directly on germ cells given the fact that estrogen does not appear 
to play a regulatory role on gonadotropin secretion (At-Tarus et al., 2006a). Estrogens have 
been shown to activate genes with AP1 and CRE promoters elements, which respectively 
binds Jun/Fos and c-Jun/ATF-2 transcription factors to mediate breast and uterine cellular 
proliferation (Peach et al., 1997) and probably a similar ER-mediated mechanism of action 
occurs in testicular germ cells to initiate and maintain their proliferative activities. 
Another direct testicular function for estradiol is inhibition of germ cell apoptosis 
(Pentikainen et al., 2000), a process that is most likely mediated via the novel non-genomic 
signalling pathway through ERs located on plasma membrane (Collins and Webb 1999).  
17-estradiol bound to membrane receptors results in rapid (within minutes) activation of 
mitogen-activated kinase signalling cascade, which in endothelial cells, has been 
associated with activation of endothelial nitric oxide synthetase and production of nitric 
oxide, which, at relevant physiological levels, has been shown to suppress apoptotic 
pathways in a variety of cell types (Kim et al., 1999). 
Although ERKO mice seemed surprisingly fertile (Krege et al., 1998), the recently 
discovered variant forms of ER (Scobie et al., 2002), including forms expressed 
specifically in normal fetal germ cells (Gaskell et al., 2003) and in testicular germ cell 
tumors (Pais et al., 2003) may have indeed supported functions originally attributed to the 
classical ER.  Moreover, its fertility was assessed between 6 and 12 weeks of age, at 
which age, also no change in testicular morphology in ArKO mice was observed 
(Robertson et al., 1999). Therefore evaluation of fertility in older ERKO animals could be 
interesting. Thus overall, understanding the role that estrogen plays in the testis is certainly 
complicated but it does appear to have subtle functions, not only at the Leydig cell but also 
possibly targeting the seminiferous epithelium, too. These roles need to be studied further 
and preferably from integrated approaches, certainly also involving animal models.
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2.7 Aims and objectives of the study 
2.7.1 Aim 
The aim of the present study was to test if in the boar testis there are sources and 
targets of estrogens like in other species. Thus, the study aimed at tracking for the presence 
of estrogen receptors  and , aromatase, steroid sulfatase and estrogen sulfotransferase 
proteins and their mRNA with age of development and spermatogenesis (Immature and 
mature boars). 
2.7.2 Objectives 
The following were the objectives of the present study. 
1. To study expression patterns of estrogen receptor  and  (targets). 
2. To confirm expression of P450 aromatase (source) 
3. To study expression patterns of steroid sulfatase and estrogen sulfotransferase, the 
enzymes likely to influence bioavailability of free estrogens in the testis. 
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3. MATERIALS AND METHODS 
3.1 Tissue Collection and Sample Preparation 
3.1.1 Experimental animals and design 
Testicular samples for this study were collected from 25 healthy Large White boars 
kept at the Liebig-University Hardthof veterinary farm in Giessen. The animals were 
randomly obtained from 5 litters, allotted to five age groups (5 animals per group) and 
castrated at ages of 50, 100, 150, 200 and 250 days. Tissue collection and conservation was 
aimed at preserving protein and mRNA in order to study their expression patterns. Porcine 
uterine control samples for ER trials were obtained from previously conserved blocks that 
were made using tissue collected from a local slaughterhouse in Giessen. 
3.1.2 Sample collection and tissue preservation 
The boars were castrated following routine clinical procedures. For anaesthesia the 
50 day-old animals were injected intramuscularly, and the older ones infused intravenously 
via the vena auricularis with a drug combination comprising of azaperone (20mg/kgbwt), 
levomethadone (0.5mg/kgbwt) and ketamine (20mg/kgbwt). 
Following removal, the testes were trimmed off the epididymides and excess 
connective tissue, cleaned off excess blood using phosphate buffered saline (PBS, pH 7.2) 
and cut longitudinally into two halves using a scalpel blade. From each half, five to six 
approximately 1 cm3 parenchyma samples were taken from the area between the tunica 
albguinea and the mediastinium testis. Samples for immunohistochemistry (IHC) and in 
situ reverse transcription polymerase chain reaction (RT-PCR) were fixed for 24h at 4°C in 
neutral phosphate buffered 4% formalin with gentle agitation. After washing in PBS and 
dehydration through a graded ethanol series (30%, 50% and 70%), the samples were 
infiltrated with paraffin (60°C) overnight, embedded in paraffin wax (Histo-Comp-Vogel, 
D-35392, Giessen) and mounted onto blocks, which were then stored at 4°C until use. 
For in vitro RT-PCR testicular parenchyma samples were frozen immediately in 
liquid nitrogen and stored at –80°C until RNA extraction. 
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3.2 Immunohistochemistry (IHC) 
3.2.1 Slide preparation 
5µm thick sections were cut from the tissue blocks using a microtome (Reichard 
Jung AG, Heidelberg), and mounted onto Super Frost-plus glass slides (Menzel Glaeser, 
D-38116 Braunschweig). The slides were mostly dried at room temperature overnight prior 
to immunostaining but in the cases when the procedure was done the same day, drying was 
achieved by letting the slides stay at 60oC for one hour. 
3.2.2 Staining procedure 
Indirect immunoperoxidase staining methods were applied using the strepavidin-
biotin technique for signal enhancement following standard procedures (Schuler et al. 
2002). Sections were deparaffinised for 2x4 min in xylene, rehydrated for 2x2 min through 
graded ethanol (99%, 95%, 70%, and 30%) and washed under running tap water (5 min). 
Antigen retrieval was achieved by pre-incubation of the rehydrated sections in 
10mM citrate buffer, pH 6.0 for 5 min prior to 3x5 min microwave irradiation in pre-
heated citrate buffer in an oven run at 560W. The slides were allowed to cool for 20min at 
room temperature, then washed for 5 min under running tap water and incubated in 0.3% 
hydrogen peroxide in methanol for 30 min to quench endogenous peroxidase activity. 
Sections were then washed with IHC buffer (phosphate buffered saline with 0.3% 
tritonX) and covered for 20 minutes with appropriate serum to block non-specific binding 
sites. Following draining of excess blocking serum, the respective primary antibodies, 
diluted in IHC buffer at appropriate dilutions (Table 4) were applied and the sections were 
incubated for 20 h (over night) at 4°C. 
In the following day, excess antibody solution was drained and the sections were 
washed 2x10 min in IHC buffer and incubated with biotinylated secondary antibody 
diluted in IHC buffer for 30 min at room temperature. Immunolocalisation of epitope 
antibodies was achieved using the streptavidin-biotin immunoperoxidase system 
(Vectastain Elite ABC Kit; Vector Laboratories, Inc., Burlingame, CA 94010, USA). After 
washing with IHC-buffer for 3x5 min immunoreactivity was visualized using Novared 
substrate kit (Vector Laboratories, Burlingame, CA94010, USA) as the chromogen. 
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Sections were then thoroughly rinsed in running tap water, lightly counterstained 
with haematoxylin, dehydrated, cleared in xylene and mounted using Histokit (Assistant, 
D-35520 Osterode). 
Negative controls were set up using the irrelevant isotype-specific antibodies (see 
table 4) at an equal concentration of the respective primary antibody. For the estrogen 
receptor isoforms, porcine uterus was used as a positive control. 
For ease of application and control, the IHC procedure was summarized in a 
tabulated format (Annex 1). 
Table 4: Details of antibodies used for immunohistochemistry 
Antigen Clone Source Immunogen Dilution Species Description 
ER HT227 Dr. H.H 
Thole 1* 
c-terminus of 
the porcine 
ER 
1:100 Mouse Mouse antipig 
ER 
monoclonal  
ER PPG5/10 Serotec, D-
40210 
Düsseldolf 
conserved c- 
terminus of 
the human 
ER1 
1:20 Mouse Mouse 
antihuman 
ER1, 
monoclonal  
Aromatase SM1671P  Acris, D-
32120 
Hidden-
hausen 
conserved 
region in 
human P450 
arom 
1:500 Mouse P450 aromatase 
primary 
monoclonal 
Steroid 
sulfatase 
 Dr. Ugele 
2* 
Epitope 
within 
human 
sulfatase 
1:2500 Rabbit Rabbit 
antihuman 
polychronal  
Estrogen 
sulfotransferase 
 Dr. 
Wenchao 
Song 3* 
Mouse EST 1:7000 Rabbit Rabbit 
antimouse EST, 
polychronal 4* 
Negative IgG1 Dianova 
GmbH, D-
20148 
Hamburg 
Non-specific 1:100 Mouse mouse isotype 
control antibody 
for ER 
negative IgG2a Vector 
Laboratorie, 
Burlingame, 
CA94010 
Non-specific 1:200 
 
 
1:500 
Mouse mouse isotype 
control antibody  
for ER and 
P450 aromatase 
Secondary 
antibody  
BA 2000 Beckman 
Coulter 
Miami, CA 
33196-2500 
Mouse IgG 1:200 Horse Biotinylated 
horse anti-
mouse IgG 
1* Dr. H. H. Thole formerly at the Max-Planck Institute for Experimental Endocrinology, Hanover; 2* Dr. B. 
Ugele in Frauenklinik Innenstadt, Universität München; 3* University of Pennsylvania, Philadelphia, USA; 4* 
negative was set up using rabbit serum. 
MATERIALS AND METHODS 
   
56 
3.2.3 Quantitative Evaluation of Positive Cells  
For quantitative assessment of ER positive cells, a person blinded for group and 
animal information, evaluated three immunostained sections from each animal for each 
receptor isoform. The types of positive staining cells were identified and in each of the 
three sections for each cell type, the total number and the numbers of ER positive cells 
were counted at a 200-fold magnification. 
In the case of sexually mature boars, from each slide, at least three different 
arbitrarily views corresponding to different stages of germ cell development (see below) 
were chosen. In immature boars three arbitrarily chosen views of approximately 200 cells 
each were evaluated. Based on the results obtained, expression of ER in the testis was 
assessed in relation to the sexual development (immature and mature), location of the cells 
(seminiferous epithelium and interstitium) and stage of spermatogenesis. The histological 
appearance of the seminiferous tubules was used to define animals as immature 
(prespermatogonia and Sertoli cells only) or mature (fully developed spermatogenesis). 
In respect to the stage of spermatogenesis, staining by IHC did not allow a 
complete application of Swierstra's criteria to divide spermatogenesis into the eight stages 
(Swierstra 1968a, b). Hence and as described by Kohler (2004), spermatogenesis was 
grossly divided into three arbitrary phases, the first immediately after spermiation without 
elongated spermatids, the second during elongation of the spermatids and the third just 
prior to spermiation with fully elongated spermatids. 
For statistical evaluation, a three-factorial partial hierarchical analysis of variance 
(age group [G], animal within age group [A (G)], section within animal and age group [S 
(AG)] using BMDP statistical software, program BMDP8V (Dixon 1993) was performed. 
3.3 In vitro reverse transcription polymerase chain reaction (RT-PCR) 
3.3.1 RNA isolation 
3.3.1.1 Extraction procedure 
Coarse pieces of deep-frozen (-85 °C) testicular parenchyma tissue were enveloped 
in sterile aluminium foil and grounded into smaller particles by hammering against a solid 
surface. The resulting particles were then powdered under liquid nitrogen using a pestle in 
a mortar, which were placed into ice for one hour prior to isolation and thereafter pre-
chilled to about -80°C using liquid nitrogen. Approximately 200mg of the ground tissue 
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were then immersed in 3ml lysis buffer containing 30µl -mercaptoethanol and 
homogenized by three times 30 sec bursts using an Ultra Turrax T25 (IKA-Werke GmbH 
& Co KG, D-79219 Staufen i.Br.). Subsequently, a silica gel based RNA extraction was 
performed according to the instructions of the kit supplier (RNeasy Mini Kit, Qiagen, D-
40724 Hilden) (Annex 2). 
3.3.1.2 Measuring concentration 
After extraction the RNA concentration in microgram per millilitre (µg/ml) was 
measured using a UV-Eppendorf BioPhotometer 6131 (BioPhotometer, Eppendorf® AG, 
Hamburg) applying wavelengths 230nm, 260nm and 280nm. A dilution of 1:20 (5µl of the 
sample in 95µl of double distilled water) in a plastic cuvette tube (Eppendorf Uvette® 220-
1600 Nm, MAGV laboratory need & laboratory instruments, Rabenau Londorf) was 
utilised. 
3.3.1.3 Standardisation of concentration and RNA storage 
In order to ensure that a uniform amount of RNA was used during RT reactions, a 
standard concentration of 200ng/µl in the working solution aliquots was prepared using 
double deionised water (DEPC-Water) from the stock solution. The following formula was 
used to achieve this concentration in 30µl of the standardised RNA solutions. 
200 ng x 30 l = measured RNA conc. (ng/l) in stock solution x Y l (required volume). 
  This means the volume (Yµl) of RNA to be drawn from the stock solution 
would be equivalent to 6000/the measured RNA conc. 
Then this volume (Yµl) from the stock RNA solution is toped up to 30µl using DEPC-
Water. 
The standardised RNA (200ng/µl) was then stored at –20°C as the working solution 
and the rest of the RNA was stored at –85°C as stock solution. 
3.3.2 RT Step of the in vitro RT-PCR 
GeneAmp RNA PCR Kit (Perkin Elmer, Foster City, CA) was used for the RT-
PCR and the first strand cDNA was synthesized from 300ng of total RNA (1.5µl of 
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200ng/µl) using 8.5µl of the RT-mix (Table 5) prepared according to the instructions of the 
kit supplier (Perkin Elmer, Foster City, CA). This was pipetted in multiples according to 
the number of mRNA samples. 
Table 5: Summarized formula for the RT-mix protocol 
Components Simple calculation 
(in µl) 
Stock solution Used solution 
MgCl2 2 25mM 5mM 
10xPCR-buffer* 1 10x 1x 
dGTP 1 10mM 1 mM 
dTTP 1 10mM 1 mM 
dATP 1 10mM 1 mM 
dCTP 1 10mM 1 mM 
Random Hexamers 0.5 50µM 2.5µM 
RNAse-Inhibitor 0.5 20U/µl 1U/µl 
Reverse Transcriptase 0.5 50U/µl 2.5U/µl 
Total volume 8.5 
*10 times concentrate of 500 mM KCl, 100mM Tris-HCl 
A one step reverse transcription was carried out in plastic tubes (Biozym 
Diagnostik GmbH, Hessisch Oldendorf) in an automated program in a T1 Thermocycler 48 
(Whatman Biometra, Göttingen) using the settings of 8 min. at 21 ºC, 15 min. at 42 ºC, 5 
min. at 99 ºC, 5 min. at 5 ºC, and then 4 ºC until withdrawal. 
3.3.3 PCR step of the RT-PCR 
The primer pairs for the PCR step were deduced from published porcine sequences 
using a computer Software Oligo Analyser 1.0.2/Oligo Explorer 1.1.0. (Free Internet 
software; © Teemu Kuulasmaa, University of Kuopio, 70211 Kuopio, Finnland), ordered 
from MWG-Biotech (D-85560 Ebensburg, Germany) and used in PCR reactions to amplify 
products of expected base pair cDNA fragments in a T1-Thermo Cycler (Biometra GmbH, 
D-37005 Göttingen) (Table 6). 
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Table 6: Primers used in RTPCR for detection of mRNA specific for ER, aromatase, 
StS and EST, their nucleotide positions (nt) in published porcine mRNA sequences 
and the length of resulting DNA fragments 
Primer Sequence utilized Position 
(nt) 
Amplicons length 
(nt) 
Accession 
No. 
ER-forward 5'-AGG GAG AGG AGT 
TTG TGT G-3' 
170 189 
ER-reverse 5'-TCT CCA GCA GCA 
GGT CAT AG-3' 
474 455 
305 AF035775 
ER-forward 5'-ACA CCT CTC TCC 
TTT AGC C-3' 
243 262 
ER-reverse 5'-CCT GAC GCA TAA 
TCA CTG-3' 
481 464 
239 AF267736 
P450arom-
forward 
5'-TTA GCA AGT CCT 
CAA GTG TG-3' 
421 440 
P450arom-
reverse 
5'-CCA GGA AGA GGT 
TGT TAG AG-3' 
744 724 
324 U37311 
EST-forward 5'-GAG AAC GAA TCC 
ACA AGT 
819 828 
EST-reverse 5'-TGC TGC TCA TAG 
TGA ATG TC 
1121 1101 
303 AF389855 
StS-forward GAA GAC AGG ATC ATT 
GAC G 
137 155 
StS-reverse AGA ACT TGG GTG TGA 
AGA AG 
308 298 
172 DQ139314 
The PCR reaction mixture per tube consisted of 10µl of cDNA sample added to 
40l of a premixed solution containing 1l primer-mix (forward and reverse; each 
15pmol/µl), 0.25l Amplitaq Gold DNA polymerase (5U/µl), 2l MgCl2 (25mM), 4l 10x 
PCR-buffer (500mM KCl, 100mM Tris-HCl) and 32.75l double distilled autoclaved 
water; this solution was prepared for a set of 15 samples. At first, MgCl2, PCR-buffer and 
DEPC water were prepared (Table 7) and thereafter the pre-mixed primer (reverse and 
forward) added (Table 8). Porcine-specific -actin primer pairs (Gen. Acc.No. SSU07786) 
were used as an internal control while negative controls were set up using autoclaved water 
instead of RNA in the RT reaction mix. 
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Table 7: Summarized PCR-premix preparation protocol 
Components Simple calculation 
(in µl) 
Stock solution Used solution 
MgCl2 2 25mM 1mM 
10xPCR-buffer* 4 10x 1x 
DEPC-H2O 32.75 
Total volume 38.75 
Table 8: Final PCR mix preparation protocol 
Components Simpler calculation 
(in µl) 
PCR-Premix 38.75 
Stock solution 
Used solution 
Primer-mix* 1.00 10pmol/µl 0.2pmol/µl  
GOLD Amplitaq 
0.25 5U/µl 0.025U/µl 
Total volume 40 
* 1l primer-mix contains both forward and reverse primers, each at 15pmol/µl. 
The hot-start PCR reaction was run for 10min at 95°C to activate Amplitaq Gold 
DNA polymerase followed by the program comprising of 35 cycles (Table 9). 
Table 9: PCR Program settings 
Program step Temperature Duration 
Initial Denaturing 94°C 1 min 
Amplification steps (Begin of cycles) 
Denaturing 94°C 1 min 
Anealing At 58.5°C (ER), 55°C (ER) 2.15min 
Extension 72°C 1.30 min 
End of cycles 
Repeated for 35 
cycles 
Final extension 72 °C 6 min 
Until withdrawal  4°C  
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3.3.4 Analysis of the PCR-amplicons by Gel electrophoresis 
The amplicons were separated and visualized on a 2% ethidium bromide stained 
agarose gel and visualized under UV transillumination. 1.82g of agarose in 91 ml of Tris-
Borate-EDTA (TBE) buffer was first heated in the microwave to dissolve completely and 
allowed to cool to about 60-65°C. Then 1.9 µl of the ethidium bromide (Table 10) (Carl 
Roth Gmbh&Co., 2218, Karlsruhe) was added, carefully mixed and poured into a 
horizontally set gel container (GibcoBRL, Life Technologies, Karlsruhe). The gel was then 
allowed to set for about 25-30 min at room temperature. 
Table 10: Protocol for preparing 2% ethidium bromide stained agarose gel 
Gel TBE-buffer (ml) Agarose (g) Ethidium bromide (l) 
Small 20 0.4 0.5 
Medium 34 0.68 0.8 
Large 91 1.82 1.9 
Meanwhile, the probe and the marker were prepared as follows: - 
Probe     1.5 l loading dye + 15 l PCR product (cDNA) 
100 bp Marker 1.5 l loading dye (6x Loading Dye Solution; MBI Fermentas, St. 
Leon-Rot) + 1.5 l Marker (100 ng/l) (MBI Fermentas, St. Leon-
Rot) + 7 l DEPC-Water 
Subsequently, the gel was immersed in TBE buffer contained in an electrophoresis 
machine (LKB Bromma, Golden, USA), the probe and the marker were loaded into the, 
wells and let to run for 35-40min under a voltage of 125 V and a current of 300 mA for the 
amplicons to separate. The separated ampilcons were then visualized under UV 
transillumination using a UV-Transluminator fitted with camera linked to Photoshop 
Software; Phoretix Grabber 3.01 (Biostep GmbH, Jahnsdorf) and photographs taken. 
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3.4 One Step in situ RT-PCR for ER and ER 
3.4.1 Introduction and slide preparation 
This method detects incorporated digoxigenin (DIG)-labelled uridine triphosphate 
(11-dUTP) in the DNA amplified in situ (Sander et al., 1996; Schiller et al., 1998). 
Sections of 5µm cut from formalin-fixed paraffin-embedded tissue were mounted onto the 
cavities of TESAP (3-triethoxysilyl-propylamine) coated Superior glass slides (Paul 
Marienfeld GmbH and Co. KG, Lauda-Koenigshofen, Germany) and dried for 1h at 37°C. 
They were then deparaffinized in xylene (15min) and rehydrated in descending 
isopropanol (100%, 70%; 5min each) series. Then the slides were air-dried for 1hr and 
subsequently washed twice in DEPC water. Permeability was improved with protease K 
(Sigma, Deisenhofen, Germany) at a concentration of 2µg/ml 0.1N HCl at 25°C for 5 min, 
which was then stopped by washing three times in DEPC water. To digest genomic DNA, 
the slides were treated overnight at 37°C in an RNase-free DNase solution (Roche 
Molecular Biochemicals, Mannheim, Germany) at a concentration of 1U/µl in DNase 
buffer (100 mM NaAc, pH 5.0; 5mM MgSO4), omitting this step constituted the positive 
controls. 
3.4.2 In situ RT-PCR step 
In the following day the slides were washed twice in DEPC water, then in 100% 
isopropanol and finally air-dried for 1hr. The in situ RT-PCR step was performed with the 
GeneAmp in situ PCR thermal cycler (System 1000; Perkin Elmer). Slides were placed on 
an assembly tool (Perkin Elmer) and overlaid with 50µl of the reaction mix containing 
29µl DEPC-H2O, 1µl each of nucleotides, the dATP, dCTP, dGTP, dTTP (each 10 mM 
stock), 1µl Dig-UTP 10mM (Roche Diagnostics GmbH, Steinheim, Germany), 6µl Mn 
(OAc) 225mM, 1µl RNAse inhibitor (Roche Diagnostics GmbH), 10µl 5'-EZ buffer (EZ 
rTth RNA PCR kit; Perkin Elmer), 3.0 µl of primers forward and reverse (20 µM stock) 
and 2µl recombinant thermus thermophilus (rTth)-DNA polymerase (2.5U/µl). They were 
then covered with mineral oil and incubated at 62C for 45min to allow for the reverse 
transcription. Cycling conditions (Table 6) and the primers (Table 3) were the same as 
described for in vitro PCR. 
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3.4.3 Washing and Immunostaining steps 
To visualize the amplified PCR products, the DIG-labelled cDNA segments were 
detected by alkaline phosphatase-conjugated sheep anti-DIG Fab fragments (Roche 
Molecular Biochemicals) diluted at 1:3000 in TRIS in situ detection buffer I (1M Tris, pH 
7.5 with NaCl) for 1hr. Initial 15 min incubation with 0.3% ovine serum prepared in 0.1x 
standard saline citrate (SSC) buffer was used to block any non-specific signals. Then the 
sections were washed for 2x15 min using SSC buffer to remove the any excess Dig-
labelled dUTP that could have been bound to the excess antibody. Subsequently, the 
sections were equilibrated in TRIS in situ detection buffer II (1M Tris-HCl, pH 9.5; 
containing NaCl and MgCl2) for 10min and reacted with the substrate 5-bromo-4-chloro-3-
indolyl phosphate (BCIP) in the presence of nitroblue tetrazolium (NBT) (Roche 
Molecular Biochemicals) (i.e., 2480µl TRIS in situ detection buffer II+11.25µl 
NBT+8.75µl BCIP) to form a dark blue precipitate at the site of the label. To stop the 
reaction, slides were washed in distilled water and embedded in glycerol gelatine. 
3.5 In situ hybridization for StS and EST 
3.5.1 Introduction 
In situ hybridization (ISH) is an effective approach for the localization of gene 
expression at the cellular level. The method is based on the specific annealing of a labelled 
probe to complementary sequences of target nucleic acids in a fixed specimen, followed by 
detection and visualization of nucleic acid hybrids with cytological methods (Baumgart et 
al., 2001). Although there are many descriptions of ISH protocols (Baumgart et al., 2001), 
none of them is universally sensitive and efficient due to the huge scope of target nucleic 
acids and wide variance of tissue types. 
3.5.2 Generation of the probes 
Total RNA from the porcine testis was reverse-transcribed using the same 
procedures as described for in vitro RT (section 3.3.2 above) and the cDNA was amplified 
using the same primers and conditions as in PCR step (section 3.3.3 above). The PCR 
products were then cut out and extracted from the gel according to the Qiagen extraction 
kit (QIEX II, gel extraction kit, Qiagen) and subsequently ligated to the pGEM-T system I 
Promega vector (Promega, WI, USA) (Fig. 12) according to the manufacturer's instructions 
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(Annex 3). The vector contained a 3` terminal thymidine to both ends which improved the 
efficiency of ligation of the PCR product and prevents recirculization of the vector. It also 
contained T7 and Sp6 RNA polymerase promoter flanking a multiple cloning region within 
the -peptide coding region of the enzyme -galactosidase. Insertional inactivation of the 
-peptide allowed recombinant clones to be directly identified by colour screening on 
indicator plates. Then the vector with the PCR insert was used for transformation of 
competent E.coli bacteria using Promega transformation protocol (Annex 4) to yield white 
recombinant colonies (with PCR inserts) against blue non-transformed colonies after 
culturing overnight in agar gel plate coated with ampicillin and tetracycline antibiotics. 
 
Fig. 9: pGEM®-T Vector and its multiple cloning sequences; the top strand of the sequence shown 
corresponds to RNA synthesized by T7 and the bottom by Sp6 (Promega manual, WI, USA). 
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A single white colony was then picked and cultured in fluid medium overnight to 
obtain multiple copies of the transformed bacteria. Subsequently the recombinant plasmids 
were isolated from the bacteria using the Promega Standard Plasmid Miniprep Procedure. 
This was followed by single digestion using either NCO1 or NOT1 restriction enzyme to 
linearize and release the T7 and/or Sp6 template DNA inserts respectively, which were 
sent for sequencing for identification. The linearized template DNA was extracted with 
phenol/chloroform (1:1), then with chloroform/isoamyl alcohol (1:1), precipitate with 
ethanol and finally dissolved in DEPC water. Following this transcription and labelling of 
the riboprobes was done through a procedure that incorporates one modified nucleotide 
(DIG-UTP) at approximately every 20 – 25th positions in the transcripts. Since the 
nucleotide concentration does not become limiting in the following reaction, 1 µg linear 
plasmid DNA (with a 1 kb insert) can produce approximately 10 µg of full-length labelled 
RNA transcript in a 2 h incubation. The reaction mixture for seven vials was prepared 
following Roche labelling kit (Roche Diagnostics GmbH, Mannheim), containing the Dig-
RNA labelling mixture of 10 mM ATP, 10 mM CTP, 10 mM GTP,  6.5 mM UTP, 3.5 mM 
DIG-UTP; in Tris-HCl, pH 7.5 (+20°C). 4µl of the purified template DNA was added to 
2µl of 10x transcription buffer, 2µl of 10x Dig-RNA labelling mixture, 1 µl of Rnase 
inhibitor and RNA Polymerase SP6 or RNA Ploymerase T7. The mixture were gently 
mixed, centrifuged briefly and incubated for 2 h at 37oC. The reaction was stopped by 
adding 2 µl 0.2 µ EDTA (pH 8.0). The probes were then stored at -20 oC until usage. 
3.5.3 In situ Hybridisation step 
5µm thick sections were deparaffinized with xylene (5 min at 60oC, 2x5 min at 
room temperature (RT), rehydrated through descending ethanol concentrations (2x5 min 
100%, shortly in 96%, 5min 70%) and shortly in DPEC water. They were then equilibrated 
(20 min 0.2N HCL, 2x15 min SSC (standard saline citrate) at 70oC and shortly in 
phosphate-buffered saline containing magnesium chloride (PBSM) and treated with 
proteinase K (40 μg/ml in PBSM at 37oC) for 25 min to enhance permeability. The slides 
were then immersed in 0.2% (w/v) glycine in PBSM (5 min) to stop protease K reaction, 
acetylated for 15 sec with 20% (v/v) acetic acid in DEPC water to denature proteins and 
then shortly put in PBSM and in 4% paraformaldehyde (10 min) for architectural 
conservation. After a short immersion in PBSM, the sections were put in pre-hybridisation 
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buffer (20% glycerol in DEPC water) for 1 hr. Meanwhile the probe and the buffer were 
prepared as follows 
Probe: 
Salmon sperm DNA           2µl 
Yeast-t-RNA           4µl 
Dig-c-RNA (probe*)  1:25 =  8µl in 200µl 
Hybridisation buffer 
20x SSC     20µl 
Denhardt`s solution      2µl 
Deionised formamide (50%) 100µl 
Dextran sulfate (50%)   40µl (pre-heated to 70oC in water bath and added lastly) 
DEPC water     24µl 
 
Note: * prepared for both sense and antisense 
Subsequently, after a short wash in 2xSCC, the sections and the probe (both sense 
and antisense) were simultaneously pre-heated for 12 min at 70oC by placing the sections 
on a hot plate surface (70oC) and the probe (14µl mixture) in a water bath (70oC) to 
denature the DNA and straighten the mRNA. During heating, the sections were fitted with 
sterile slide frames to provide cavities (wells) over them. Thereafter, the sections were 
placed onto a ice-cooled surface and the probe into ice-cooled water. The probe (14µl) was 
then added into the buffer (146µl) and mixed, then the pre-heated dextran sulfate (40µl) 
was added and finally 100µl of this mixture (hybridization solution) was applied over each 
section. This was covered with sterile cover sterile slips and incubated in a formamide-
humidified chamber at 37°C overnight. 
3.5.4 Washing and Immunostaining 
After hybridization the sections were sequentially washed with 4x10 min 4xSSC at 
37°C, 15 min 2xSSC at 60oC, 15 min 0.2xSSC at 42oC, 5 min 0.1xSSC at RT and 5 min 
2xSSC at RT. Then they were incubated with 3 % (w/v) ovine serum in situ detection 
buffer I (30µl ovine serum in 970µl buffer) at RT for 1 hr to block non-specific signals.  
The sections were then incubated in a humidified chamber overnight at 4°C with 
sheep anti-DIG antibody conjugated with horseradish peroxidase (Boehringer Mannheim 
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GmbH, Germany), diluted to 1:5000 in buffer 1 containing 1% blocking reagent (2.485ml 
buffer I, 15µl ovine serum and 1µl anti-Dig antibody). 
On the third day, the sections were first washed with in situ detection buffer 1 
(2x10 min), buffer II (5 min) and buffer II+1M levamisol (200µl in 50ml buffer) (5 min) at 
RT. Then the immunoreactions were visualized by reacting the sections with the substrate 
5-bromo-4-chloro-3-indolyl phosphate (BCIP) in the presence of nitroblue tetrazolium 
(NBT) (Roche Molecular Biochemicals) (i.e., 2480µl TRIS in situ detection buffer 
II+11.25µl NBT+8.75µl BCIP) to form a dark blue precipitate at the site of the label. To 
stop the reaction, slides were incubated in buffer II+levamisol (5 min), then washed in 
distilled water and embedded in glycerol gelatine. 
Negative controls were the anti-sense probes and the results were observed under a 
light microscope with a colour camera linked to a computer system with Photoshop 
software (Leica, Wetzlar, Germany). 
3.6 Buffers and Solutions 
Ethanol (Alcohol)-Series 
Ethanol (95 %)     Ethanol (70 %) 
Pure ethanol (100%) 95 ml    Pure ethanol (100 %) 70 ml 
Deionised water 5 ml    Distilled water 30 ml 
Neutral (pH 7.0) phosphate buffered 4 % Formalin tissue fixative (Lillie 1951)  
Formalin (app. 40 % aqueous Formaldehyde solution) 500 ml  
NaH2PO4 x H2O      20 g 
Na2HPO4       32.50 g 
Deionised water      500 ml 
0.3 % H2O2 solution 
30% H2O2        2 ml 
Deionised water      200 ml 
IHC-buffer (pH 7.2-7.4) 
Na2HPO4       1.2 g 
KH2PO4        0.2 g 
KCl        0.2 g 
NaCl        8.0 g 
Double deionised water      ad 1 Liter 
After pH-control (7.2-7.4)     3 ml Triton X-100 
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Paraformaldehyde tissue fixative (pH 7.4) 
Paraformaldehyde      4 g 
Distilled water      95 ml 
20 x PBS       5 ml 
NaOH (1,025 N)      150 µl  
Heated at 70 °C, until all solute dissolves and thereafter stored at -20 °C; thawed just 
before use.  
PBS (Phosphate Buffered Saline) pH 7 .2 
5 x Stock solution: 
NaCl       41 g 
Na2HPO4 x 2H2O     11 g 
KH2PO4      2.75 g 
Double deionised water    1 Litre 
1x PBS working solution  
5 x PBS      200ml 
Double deionised water    ad 1000ml 
PBS-MgCl2 buffer (PBSM buffer) 
PBS-Tablet       1 
Double deionised water     200 ml 
1 M MgCl2 solution      1 ml 
PBST-buffer 
PBS-Puffer (pH 7.5)      1000 ml 
Tween 20       1 ml 
Citrate buffer (pH 6.0) 
Stock solution A: 0.1 M citronic acid   Stock solution B: 0.1 M sodium citrate 
C6H8O7 x H2O  21.0 g    C6H5O7Na3 x 2H2O  29.41 g 
Deionised water  ad 1 Litre   Distilled water  ad 1 Litre 
Working solution 
Stock solution A:  9 ml 
Stock solution B:  41 ml 
Deionised water  450 ml 
Phosphate buffer for tissue stabilisation during Formalin fixation 
Solution 1: 
NaH2PO4 x H2O      13.8 g 
Deionised water      ad 1000ml 
Solution 2: 
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Na2HPO4 x 2H2O      17.8 g 
Deionised water      ad 1000 ml 
Used buffer 
Solution 1: 14.15 ml 
Solution 2: 35.85 ml 
0.5 M EDTA Na2 x 2H2O (Ethylenediaminetetraacetic acid disodium dihydrate) 
EDTA Na2 x 2H2O      37.22 g 
Distilled water      ad ca. 160 ml 
pH-control by adding ca. 4 g NaOH to pH 8.0 
Double deionised water     ad 200ml 
In situ detections buffer I (1M Tris with Nacl pH 7.5) 
TRIS-HCL       12.70 g 
TRIZMA Base      2.36 g 
NaCl        8.76 g 
Double deionised water     ad 1000 ml 
In situ detections buffer II (1M Tris with Nacl and MgCl2, pH 9.6) 
TRIS-HCL       1.52 g 
TRIZMA Base      10.94 g 
NaCl        5.84 g 
MgCl2        4.76 g 
Deionised water      ad 1000 ml 
10x TBE Buffer (Tris-Borate-EDTA)  
Tris base       108 g  
Borate        55 g 
0.5 M Na4EDTA (pH 8.3)     40 ml 
Deionised water      ad 1000 ml 
1x TBE Buffer (Tris-Borate-EDTA)  
10 x TBE       100 ml 
Deionised water      ad 1000 ml 
20 x SCC, pH 7.0 (Standard saline citrate) 
C6H5O7Na3 x 2H2O      88,23 g 
NaCl        175,29 g 
Deionised water      ad 1000 ml 
Paraformaldehyde solution, pH 7.0 used during in situ-hybridisation 
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Paraformaldehyde      25 g 
1 x PBS-MgCl2-buffer     500 ml 
  Add 4 N NaOH-solution until it clears (colourless) 
Proteinase K for in situ RT-PCR (2 µg/ml) 
Proteinase K (10mg/ml)     2µl 
PBSM  buffer       100µl 
Proteinase K for in situ hybridisation (20 µg/ml) 
Proteinase K (10mg/ml)     20µl 
PBSM  buffer       80µl 
50 % Dextran sulfate solution 
Dextran sulfate      5 g 
Double deionised water     10 ml 
Stored at –20 °C  
Denhard reagent 
BSA        200 mg 
Ficoll 400       200 mg  
Polyvinylpyrrolidone      200 mg 
Double deionised water     10 ml 
Levamisol solution for quenching endogenous AP-activity 
Levamisol       2.4 g 
1 x sodium chloride Tris buffer    10 ml 
20 % acetic acid 
Acetic acid       40 ml 
Double deionised water     160 ml 
Stored at 4 °C  
1 M MgCl2 solution 
MgCl2        81.4 g 
Double deionised water     ad 400 ml 
0.2 % glycine solution  
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Glycine       200 mg 
PBS-MgCl2 buffer      100 ml 
Stored at RT 
3.7 Reagents and Sources 
 -Mercaptoethanol: M-3148 (Sigma-Aldrich Chemie GmbH, Deisenhofen) 
 100 bp DNA marker (MBI Fermentas, St. Leon-Rot) 
 ABC-reagent: Vector® - VECTASTAIN® Elite ABC Kit, PK-6101, Rabbit IgG 
(Vector Laboratories, Burlingame, CA 94010, USA via Linaris Biologische Produkte 
GmbH, D97877 Wertheim) 
 Anti-DIG-Fab-Antibody: Nr.: 1093274 (Roche Diagnostic GmbH, Mannheim)  
 BA2000; Horse antimouse IgG biotinylated antibody (Vector Labolatories. Inc., 
Burlingane, USA) 
 BCIT: 5-bromo-4-chloro-3-indolyl-phosphate, toluidine salt; Stock Solution: Art. Nr.: 
1383221 (Roche Diagnostic GmbH, Mannheim)  
 Boric acid, Pufferan® (H3BO3): Art. Nr.: 6943.2 (Carl Roth GmbH + Co., Karlsruhe) 
 Bovine Serum Albumin (BSA): Art. Nr.: 05482 (Fluka, Neu-Ulm) 
 Citronic acid monohydrate (Merck KGA, Darmstadt) 
 Denhard´s Solution: (Sigma-Aldrich Chemie GmbH, Deisenhofen) 
 Dextran sulfate (Sigma-Aldrich Chemicals GmbH, Deisenhofen) 
 Diethylpyrocarbonate (DePC; Roth GmbH & Co., Karsruhe) 
 DIG RNA Labelling Kit (SP6 / T7) : (Roche Diagnosic GmbH, Mannheim) 
 Di-sodium hydrogen phosphate -dihydrate: Art. Nr: 6580 (Merck KGaA, Darmstadt) 
 Di-sodiumydrogen phosphate solution: Art. Nr.: 6585 (Merck KGaA, Darmstadt) 
 DNase 1, RNase-free, 10 U/µl (Roche Molecular Biochemicals, Mannheim) 
 E. coli (XL-1 Blue) (Stratagene Europe, Holland) 
 EDTA Sodium (Roth GmbH & Co., Karsruhe) 
 Ethanol: 99.6%, DAB 10, Art.Nr.: 5054.5 (Carl Roth GmbH + Co., Karlsruhe) 
 Ethidium bromide 1% solution: Art. Nr.: 2218.1 (Carl Roth GmbH + Co., Karlsruhe) 
 Formaldehyde: Art. Nr.: 3999 (Merck KGaA, Darmstadt) 
 Formamide:  Art Nr.: 47671 (Fluka, Neu-Ulm) 
 Gene Amp RNA Core Kit®: (Perkin Elmer Applied Biosystems GmbH, Weiterstadt) 
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 Glycerine Rotipuran®: 99.5 % Wasserfrei Art. Nr.: 3783.1 (Carl Roth GmbH + Co., 
Karlsruhe) 
 Glycine: G-7126 (Sigma-Aldrich Chemie GmbH, Deisenhofen) 
 Gold PCR Core kit (Perkin Elmer Applied Biosystems GmbH & Co., Karsruhe) 
 HCL: 37 %, Art. Nr.: 906 K11409117 (Merck KGaA, Darmstadt) 
 Hefe-tRNA (Sigma-Aldrich Chemie GmbH, Deisenhofen) 
 Histokitt No: 1025/100 (Assistent, D-37520, Osterode). 
 Hydrogen peroxide 30 %, Art. Nr.: 64271 (Merck KGaA, Darmstadt) 
 Isopropanol (Roth GmbH & Co., Karsruhe) 
 Levamisol: L-9756 (Sigma-Aldrich Chemie GmbH, Steinheim)  
 Magnesium Chloride: M-0250 (Sigma-Aldrich Chemie GmbH, Steinheim) 
 Marker buffer for Electrophoresis: Roti®-Load 1 (4x-Konz) Art. Nr.: K929.1 (Carl 
Roth GmbH + Co., Karlsruhe) 
 Methanol: Art. Nr.: 1.06008.2500 (Merck KGaA, Darmstadt) 
 MsIgG2a: CA 33196-2500 (Beckman Coulter Miami, USA) 
 NTB: 4-Nitroblue Tetrazolium Chloride, Art. Nr.:1383213 (Roche Diagnostics GmbH, 
Mannheim) 
 Pap Pen: (G.Kisker Biotech, Steinfurt) 
 Paraformaldehyde: Art. Nr.: 76240 (Fluka, Neu-Ulm) 
 Peroxidase Kit: Vector® (Nova-RED), SK-4800: (Linearis Biologische Produkte 
GmbH, Wertheim) 
 pGEM-T-Vector (pGEM-T Vector System 1; Promega GmbH, Manheim) 
 Phosphate Buffered Saline Tablets: P-4417 (Sigma-Aldrich Chemie GmbH, 
Deisenhofen) 
 Potasium chloride reinst: Art. Nr.: 4936 (Merck KGaA, Darmstadt) 
 Potasium dihydrogen phosphate: (Fluka Chemie GmbH, Buchs) 
 Potasium phosphate monobase:  Art. Nr.: 60220 (Fluka, Neu-Ulm) 
 Proteinase K: P-2308 (Sigma-Aldrich Chemie GmbH, Deisenhofen) 
 QIAquick® PCR Purification Kit: (Qiagen Gmbh, Hilden) 
 RNase inhibitor, 40 U/µl (MBI Fermentas, St. Leon-Rot) 
 RNase-Away: (Molecular Bioproducts, San Diego, USA) 
 rTth PCR Kit (Pelkin Elmer Applied Biosystems GmbH, Weitstadt) 
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 Salmon Testes DNA: D-7656 (Sigma-Aldrich Chemie GmbH, Deisenhofen) 
 Sodium chloride: Art. Nr.: 71367 (Fluka, Neu-Ulm) 
 Sodium hydrogen phosphate-monohydrate: Art. Nr.: 6346 (Merck KGaA, Darmstadt) 
 Sodium hydroxide:  Art. Nr.: 60164531 (Merck KGaA, Darmstadt) 
 T7-RNA-Polymerase, Sp6-RNA-polymerase, 5x Transcriptions buffer (Promega, 
Manhein) 
 Tris hydroxymethylaminomethane (Trizma® Base): T-4661 (Sigma-Aldrich Chemie 
GmbH, Deisenhofen)  
 Tris-sodium citrate-dihydrate: Art. Nr.: 6448, 302 K 10020548 (Merck KGaA, 
Darmstadt) 
 Triton 100: Serva Feinbiochemica Art. Nr.: 37238 (Serva, Heidelberg) 
 Tween 20: Polyoxyethylenesorbitan Monolaurate, P-1379 (Sigma-Aldrich Chemie 
GmbH, Deisenhofen) 
 Vectastain Mouse IgG Elite kit (Vector Laboratories. Inc., Burlingame, USA) 
 X-gal 
 Xylol: Art. Nr.: 8.18754.2500 (Merck KGaA, Darmstadt) 
3.8 Materials, Equipments and their Sources 
 ACS: 180®; Automated Chemiluminescence System, Bayer (Ciba-Geigy GmbH, D-
79662 Wehr) 
 Slides, Menzel-Gläser: SuperFrost®, 24x40 mm, 24x50 mm und 24x60 mm, Art. 
Nr.:31800 AMNZ – (MAGV Laborbedarf, Rabenau-Londorf) 
 Eppendorf Biophotometer: (Eppendorf AG, Hamburg) 
 Embedding automatic machine: (Microm Laborgeräte GmbH, Heidelberg) 
 Embedding medium: Histokitt (Assistent, D-37520, Osterode) 
 Mikrotome blade: Leica DB 80L, Order No: 0358 37040, Leica Microsystems 
(Nußloch GmbH, Nußloch)  
 Elektrophoresis machine-Agarosegel: (GibcoBRL, Life Technologies, Karlsruhe)  
 Hand gloves UniGloves® : (MAGV Laborbedarf + Laborgeräte Rabenau-Londorf) 
 Lab water deminiralisation system: Aqua demineralisata Seral-Anlage mit 
angeschlosener Millipore-Reinigungsanlage: Milli Q, Water Purification System Firma 
Millipore, Typ MQ 4-fach UF (Millipore Gmbh, Eschborn) 
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 Microtome:  (Reichard Jung AG, Heidelberg) 
 Paraffin machine: Histoembedder EG 1160 (Leica Instruments GmbH, Nußloch) 
 PapPen: (G. Kisker - Biotech, Steinfurt) 
 PCR-Tubes: 0,5 ml, ultradünn, RNase-/DNase-Pyrogenfrei (Biozym Diagnostik 
GmbH, Hessisch Oldendorf) 
 pH-Meter: (MAGV Laborbedarf + Laborgeräte Rabenau-Londorf) 
 Vacuum Pump: KNF Neuber, Typ: No 035.1.2 AN. 18, Nr: 472678; VDE 0530, Nr: 
83424, Motortyp: MW 63/4, IP 44, Volt:220, 1,8 A, 0,12kW, 50 Hz, 1400 U/min 
(Freiburg) 
 Powersupply (PCR): 2301 Macrodrive 1 Powersupply (LKB Bromma, Golden, USA) 
 Reactions tubes: Biozym Scientific GmbH, Art. Nr: D-31833 (D-31833, Oldendorf) 
 Pipettes: 50 µl Rheodyne Cat. Nr.: 7205 ((Eppendorf AG, Hamburg) 
 T1 Thermocycler 49: (Whatman Boimetra, Göttingen) 
 Ultra-Turrax ®: T-8 mit Dispergierwerkzeug S8 N-5g (IKA-Werke GmbH, Staufen) 
 UV-Transluminator with Photoshop software Phoretix Grabber 3.01: (Biostep GmbH, 
Jahnsdorf) 
 UV-Spectrometer (BioPhotometer, Eppendorf® AG, Hamburg) mit Eppendorf 
Uvette® 220-1600 nm (MAGV Laborbedarf + Laborgeräte Rabenau-Londorf) 
 Vortexer: Heidolph REAX control (MAGV, Rabenau-Londorf) 
 Water bath: Typ WB-24; V220; W 550; Fabrik-Nr.;8810, max. 90C; (Medax Nagel 
KG Kiel) 
 Warm chamber: Memmert, Typ: 3 26, F-Nr: 340 073, 220 Volt, 380 Watt, 50/60 Hz, 
Din 12880-Kl. 0, Nenntemp.: 70C, Schutzart Din 40050-IP20 (Schwabach) 
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4. RESULTS 
4.1 Expression of estrogen receptors 
4.1.1 Immunolocalisation of ER by IHC 
4.1.1.1 Positive control experiments 
In the porcine uterus used as positive control, a strong immunostaining for the ER 
and ER was found in the glandular epithelium (arrow 1), weak signals were detected in 
the luminal epithelium (arrow 2) (Fig. 10a, b). 
 
Fig. 10a: ER immunostaining in porcine uterus used as positive control. A strong immunoreactivity 
was observed for ER in the glandular epithelium (arrow 1) and weak immunoreactivity in luminal 
epithelium (arrow 2). Magnification X200, bar = 50µm. 
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Fig. 10b: ER immunostaining in porcine uterus used as positive control. A strong immunoreactivity 
was observed for ER in the glandular epithelium (arrow 1) and weak immunoreactivity in luminal 
epithelium (arrow 2). Magnification X200, bar = 50µm. 
4.1.1.2 Negative control for ER in porcine uterus 
In the negative controls in the porcine uterus, apart from the occasional traces of a 
weak non-specific staining in the lumen of blood vessels (black arrow), obviously 
associated with residual serum components, there were no other non-specific signals 
(Fig. 11a). 
 
Fig. 11a: Negative control slide in the 
porcine uterus using non-specific 
mouse IgG isotypes. Only traces of weak 
non-specific staining were observed in the 
lumen of the blood vessels (arrow). 
Magnification X200 
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4.1.1.3 Negative control for ER in 50-day old boars 
In the negative controls in the juvenile boar testis, which were conducted using the 
respective mouse non-specific IgG isotypes, there were no traces of any signals (Fig. 11b) 
 
Fig. 11b: Negative control slide in 
the 50 day old boar testis using non-
specific mouse IgG isotypes. 
Magnification X200 
 
 
 
 
 
 
 
4.1.1.4 Negative control for ER in mature boars 
In the negative controls in the mature boar testis (day 150-250), which were also 
conducted using the respective mouse non-specific IgG isotypes, there were no traces of 
any signals (Fig. 11c) 
 
Fig. 11c: Negative control slide in 
the mature boar testis using 
non-specific mouse IgG isotypes. 
Magnification X200 
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4.1.1.5 ER in 50 day old boars (immature) 
For ER immunoreactivity was observed in 90.6 ± 1.2% of the prespermatogonia 
(arrow 1) and 71.2 ± 2.6% of the Leydig cells (arrow 2) (Fig. 12 and Table 11a, b). Sertoli 
cells (arrow 3) were negative 
 
Fig. 12: Immunolocalisation of ER in 50-day old boar testis. A strong immunoreaction was observed 
only in prespermatogonia (arrow 1) and in the Leydig cell (arrow 2) while the Sertoli cell (arrow 3) showed 
no reactivity. Mg=x400, bar = 50µm 
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Table 11a: Prespermatogonia staining positive for the ER in 50 day old boars (E1-
E5) 
Prespermatogonia counted % positive  
Boar slide    Positive Negative Total slide boar 
E1 A 29 5 34 85.29  
 B 16 1 17 94.12  
 C 33 2 35 94.29 91.23 
       
E2 A 23 5 28 82.14  
 B 17 1 18 94.44  
 C 29 2 31 93.55 90.05 
       
E3 A 23 4 27 85.19  
 B 23 3 26 88.46  
 C 21 1 22 95.45 89.70 
       
E4 A 22 1 23 95.65  
 B 20 4 24 83.33  
 C 25 3 28 89.29 89.42 
       
E5 A 31 2 33 93.94  
 B 27 4 31 87.10  
 C 24 1 25 96.00 92.35 
Mean ( ) = 90.55, Standard deviation (SD) = 1.22 
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Table 11b: Leydig cells staining positive for the ER in 50 day old boars (E1-E5) 
Leydig cells counted % positive 
Boar Slide Positive Negative Total 
%Positiv
e Average 
E1 A 44 13 57 77.19  
 B 34 17 51 66.67  
 C 35 19 54 64.81 69.56 
       
E2 A 40 11 51 78.43  
 B 25 18 43 58.14  
 C 38 17 55 69.09 68.55 
       
E3 A 29 12 41 70.73  
 B 23 11 34 67.65  
 C 31 12 43 72.09 70.16 
       
E4 A 42 6 48 87.50  
 B 32 12 44 72.73  
 C 28 18 46 60.87 73.70 
       
E5 A 24 14 38 63.16  
 B 36 9 45 80.00  
 C 31 8 39 79.49 74.22 
Mean ( ) = 71.24, Standard deviation (SD) = 2.56 
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4.1.1.6 ER in 50 day old boars  
In immature boars, 95.5 ± 3.5% of the prespermatogonia cells (arrow 1) (Table 12) 
showed a strong immunoreactivity for the ER (Fig 13). The Leydig- (arrow 2) and the 
Sertoli cells (arrow 3) were negative. 
 
Fig. 13: Immunolocalisation of ER in 50-day old boar testis. A strong immunoreaction was observed 
only in prespermatogonia (arrow 1) while the Leydig cell (arrow 2) and the Sertoli cells (arrow 3) showed no 
reactivity (2). Mg=x400, bar = 50µm 
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Table 12: Prespermatogonia staining positive for the ER in 50 day old boars (E1-E5) 
Prespermatogonia counted % positive 
Boar identity Slide positive negative total Slide boar 
E1 A 31 0 31 100,.0  
 B 17 1 18 94.44  
 C 37 0 37 100.00 98.15 
       
E2 A 28 1 29 96.55  
 B 19 0 19 100,00  
 C 27 1 28 96.43 97.66 
       
E3 A 20 4 24 83.33  
 B 24 2 26 92.31  
 C 25 1 26 96.15 90.60 
       
E4 A 23 1 24 95.83  
 B 19 1 20 95.00  
 C 22 3 25 88.00 92.94 
       
E5 A 30 0 30 100.00  
 B 19 1 20 95.00  
 C 28 0 28 100.00 98.33 
Mean ( ) = 95.54, Standard deviation (SD) = 3.54 
 
4.1.1.7 ER in sexually mature boars (250 day old group) 
As identified in fig. 14b, ER showed a strong immunoreactivity in 93.6±2.7% 
(Table 13a, b) of the spermatogonia (arrow 1) and primary spermatocytes (arrow 2). With 
the exception of a few cells, a distinctly less intensive staining was observed in 
51.4±0.27% (Table 13c) of the other germ cells (arrow 3) except elongating/ed spermatids 
(arrow 6), which stained clearly negative. Most of the Sertoli cells (arrow 4) stained 
weakly positive and 61.1±3.4% (Table 13d) of the Leydig cells (arrow 5) exhibited a weak 
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to distinct staining. The immunoreactivity observed showed no differences in respect to the 
stage of spermatogenesis (Fig.14a-c) i.e., no qualitative and/or quantitative changes with 
respect to seminiferous tubules were observed immediately after spermiation (phase I), 
during spermatid elongation (phase II) and prior to spermiation (phase III). 
(a) Phase I of spermatogenesis (immediately after spermiation, no elongated spermatids) 
 
Fig. 14a: ER in 250-day boar testis during phase I of spermatogenesis showing strong signals in 
spermatogonia and primary spermatocytes. Round spermatids, Sertoli cells and Leydig cells are weakly 
positive. Elongated spermatids are absent in this phase. Mg=400 
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(b) Phase II of spermatogenesis (elongating spermatids) 
 
Fig. 14b: ER in 250-day boar testis during phase II of spermatogenesis showing strong signals in 
the spermatogonia (arrow 1) and primary spermatocytes (arrow 2). Round spermatid (arrow 3), Sertoli- (arrow 
4) and Leydig cells (arrow 5) were weakly positive while elongated spermatids (arrow 6) were distinctly 
negative. Mg=400 
 
 
RESULTS  
   
85 
 
 
 
 
(c) Phase III of spermatogenesis (Fully elongated spermatids ready for release) 
 
Fig. 14c: ER in 250-day boar testis during phase III of spermatogenesis showing strong signals in 
spermatogonia and primary spermatocytes. Round spermatids, Sertoli cells and Leydig cells are weakly 
positive while elongated spermatid are negative. Mg=400 
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Table 13a: Spermatogonia staining positive for ER in the mature boars 
Spermatogonia counted 
Boar Slide Positive Negative Total %Positive Average 
E1 A 46 4 50 92.00  
 B 45 5 50 90.00  
 C 47 5 52 90.38 90.79 
       
E2 A 54 1 55 98.18  
 B 38 1 39 97.44  
 C 44 1 45 97.78 97.80 
       
E3 A 42 1 43 97.67  
 B 47 5 52 90.38  
 C 43 3 46 93.48 93.85 
       
E4 A 39 7 46 84.78  
 B 50 1 51 98.04  
 C 46 4 50 92.00 91.61 
       
E5 A 49 1 50 98.00  
 B 47 5 52 90.38  
 C 48 3 51 94.12 94.17 
 
Mean ( ) = 93.64, Standard deviation (SD) = 2.73 
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Table 13b: Primary spermatocytes staining positive for ER in mature boars 
Primary spermatocytes counted 
Boar Slide Positive Negative Total %Positive Average 
E1 A 47 2 49 95.92  
 B 57 1 58 98.28  
 C 49 5 54 90.74 94.98 
       
E2 A 56 5 61 91.80  
 B 58 6 64 90.63  
 C 54 1 55 98.18 93.54 
       
E3 A 56 2 58 96.55  
 B 57 0 57 100.00  
 C 53 3 56 94.64 97.06 
       
E4 A 52 6 58 89.66  
 B 53 3 56 94.64  
 C 48 3 51 94.12 92.81 
       
E5 A 54 1 55 98.18  
 B 57 9 66 86.36  
 C 45 8 53 84.91 89.82 
Mean ( ) = 93.64, Standard deviation (SD) = 2.69 
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Table 13c: Round spermatids and/or secondary spermatids) within the seminiferous 
tubules staining positive for ER in mature boars 
Cells counted 
Boar Slide Positive Negative Total %Positive Average 
E1 A 89 86 175 50.86  
 B 91 85 176 51.70  
 C 90 87 177 50.85  
      51.14 
E2 A 85 80 165 51.52  
 B 74 72 146 50.68  
 C 77 71 148 52.03  
      51.41 
E3 A 73 70 143 51.05  
 B 71 66 137 51.82  
 C 66 63 129 51.16  
      51.35 
E4 A 76 71 147 51.70  
 B 94 90 184 51.09  
 C 90 87 177 50.85  
      51.21 
E5 A 63 60 123 51.22  
 B 97 86 183 53.01  
 C 103 98 201 51.24 
           
51.82 
Mean ( ) = 51.37, Standard deviation (SD) = 0.27 
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Table 13d: Leydig cells staining positive for ER in mature boars 
Leydig cells counted 
Boar Slide Positive Negative Total %Positive Average 
E1 A 78 52 130 60.00  
 B 72 48 120 60.00  
 C 66 62 128 51.56  
      57.19 
E2 A 81 40 121 66.94  
 B 60 44 104 57.69  
 C 78 65 143 54.55  
      59.73 
E3 A 83 57 140 59.29  
 B 81 26 107 75.70  
 C 68 54 122 55.74  
      63.57 
E4 A 66 41 107 61.68  
 B 84 49 133 63.16  
 C 63 25 88 71.59  
      65.48 
E5 A 79 51 130 60.77  
 B 51 29 80 63.75  
 C 67 58 125 53.60         59.37 
Mean ( ) = 61.07, Standard deviation (SD) =3.37 
4.1.1.8 ER in the other groups (100-, 150- and 200-day old boars) 
4.1.1.9 ER in 100-day old boars 
Day-100 old boars represented the sexually maturing group for which the tubules 
were predominantly filled with spermatogonia and primary spermatocytes with 
occasionally few visible elongated spermatids. In this group, apart from the myoid cells 
(arrow 1) and the elongating spermatids (arrow 2), virtually all the other cells within the 
seminiferous tubules were positive with the spermatogonia (arrow 3) and the primary 
spermatocytes (arrow 4) being intensively positive (Fig. 15a). Like in day-250 group the 
Leydig (arrow 5) and Sertoli cells (arrow 6) were also positive. 
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Fig. 15a: ER in 100-day boar testis showing strong signals in spermatogonia (arrow 3) and 
primary spermatocytes (arrow 4) while weaker reactions were observed in round spermatids 
(arrow 4), Leydig- (arrow 5) and Sertoli cells (arrow 5). The myoid cells (arrow 1) and 
elongating spermatids (arrow 2) were negative. Mg=200 
4.1.1.10 ER in 150- and 200-day old boars 
The pattern of ER expression in day-150 group (Fig 15b) and day-200 group (Fig. 
15c) was the same as in day-250 group. As shown for the day-150 group (Fig 15b), apart 
from the myoid cells (arrow 1) and elongated spermatids (arrow 2), all the other cells are 
positive. The spermatogonia (arrow 3) and primary spermatocytes (arrow 4) showed a 
strong immunoreaction. The round spermatids (arrow 5), Leydig- (arrow 7) and Sertoli 
cells (arrow 6) were weakly positive. 
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Fig. 15b: ER in 150-day boar testis showing strong signals in spermatogonia (arrow 3) and primary 
spermatocytes (arrow 4) while weaker immunoreactions were observed in Leydig- (arrow 7) and Sertoli cells 
(arrow 6). Mg=400 
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Fig. 15c: ER in 200-day boar testis. Apart from the negative myoid cells (arrow 1), elongated- (arrow 2) 
and elongating spermatids (arrow 3), strong signals were observed in spermatogonia and primary 
spermatocytes, and weaker reactions in Leydig and Sertoli cells. Mg=200 
4.1.1.11 ER in sexually mature boars (250 day old group) 
With exception of elongating/ed spermatids (arrow 6) in the sexually mature group 
of boars virtually all (94.85% ± 1.6, see Table 14), the Sertoli (arrow 4), Leydig- (arrow 5) 
and germ cells (arrows 1-3) (see in Fig. 16b)  stained positive for the ER. Like it was the 
case for ER, the pattern of ER expression was the same during the three phases of 
spermatogenesis (Fig. 16a c). 
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(a) Phase I of spermatogenesis (immediately after spermiation, no elongated spermatids) 
 
Fig. 16a: ER in 250-day boar testis during phase I of spermatogenesis showing signals in 
spermatogonia, primary spermatocytes, round spermatids, Sertoli cells and Leydig cells. Elongated 
spermatids are absent in this phase. Mg=400 
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(b) Phase II of spermatogenesis (elongating spermatids) 
 
Fig. 16b: ER in 250-day boar testis during phase II of spermatogenesis showing signals in 
spermatogonia (arrow 1), primary spermatocytes (arrow 2), round spermatids (arrow 3), Sertoli- (arrow 4) and 
Leydig cells (arrow 5). Elongated spermatids (arrow 6) were distinctly negative (6). Mg=X400 
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(c) Phase III of spermatogenesis (Fully elongated spermatids ready for release) 
 
Fig. 16c: ER in 250-day boar testis during phase III of spermatogenesis showing signals in 
spermatogonia, primary spermatocytes, round spermatids, Sertoli cells and Leydig cells. Elongated 
spermatids are negative. Mg=400 
 
RESULTS  
   
96 
 
 
 
 
Table 14: Germ cells (except elongating/ed spermatids), Sertoli- and Leydig cells 
staining positive for the ER in the seminiferous tubules of 250-day old boars (E1-E5) 
Cells counted in mature seminiferous tubular cells 
Boar   Slide ER positive ER negative Total cells %positive Boar 
E1 A 195 7 202 96.53 Mean SD 
 B 193 11 204 94.61   
 C 189 2 191 98.95   
      96.70 3.45 
E2 A 180 12 192 93.75   
 B 164 2 166 98.80   
 C 149 17 166 89.76   
      94.10 6.43 
E3 A 173 10 183 94.54   
 B 172 7 179 96.09   
 C 177 3 180 98.33   
      96.32 3.85 
E4 A 175 7 182 96.15   
 B 174 22 196 88.78   
 C 169 5 174 97.13   
      94.02 6.53 
E5 A 166 7 173 95.95   
 B 150 16 166 90.36   
 C 174 13 187 93.05 93.12 7.45 
Mean ( ) = 94.85, Standard deviation (SD) = 1.57 
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4.1.1.12 ER in the other groups (100- 150- and 200- day old boars) 
4.1.1.13 ER in 100- day old boars  
As for ER in day-250 old boars, apart from the myoid cells (arrow 1) and the 
elongating spermatids (arrow 2), virtually all the other cells within the seminiferous 
tubules were equivalently positive (Fig. 17a), which includes the Sertoli cells (arrow 3) the 
spermatogonia (arrow 4), the primary spermatocytes (arrow 5) and round spermatid (arrow 
6). 
 
Fig. 17a: ER in 100-day boar testis showing signals in Sertoli cells (arrow 3), spermatogonia (arrow 4), 
primary spermatocytes (arrow 5) and round spermatids (arrow 6). Myoid cells (arrow 1) and elongating 
spermatids (arrow 2) are negative. Mg=400 
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4.1.1.14 ER in 150- and 200-day old boars 
Like it was the case for day-250 group, in day-150 (Fig 17b) and day-200 groups 
(Fig. 17c), ER was expressed at similar intensity in all cell types except in elongating and 
elongated spermatids.  
 
Fig. 17b: ER in 150-day boar testis showing signals in all cell types except in elongating/ed spermatids. 
Mg=X200 
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Fig. 17c: ER in 200-day boar testis showing signals in all cell types except in elongated/ing spermatids. 
Mg=200 
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4.1.2 Detection of ER-Specific mRNA  
4.1.2.1 In vitro RT-PCR 
One specific band of the expected base pairs corresponding to the respective ER 
isotype mRNA (Table 6) was detected during in vitro RT-PCR in all testicular samples 
from all age groups and porcine uterus (Fig.18). Sequencing of PCR products (Qiagen) 
yielded 95 and 92% similarity with the respective porcine mRNA sequences for ER and 
ER, respectively. 
 
Fig. 18: Ethidium bromide-stained agarose gel of in vitro RT-PCR analysis for the presence of 
mRNA specific to (a) ER and (b) ER. 1 = 50 days, 2 = 100 days, 3 = 150 days, 4 = 200 days and 
5 = 250 days testicular samples; M, DNA ladder; P, porcine uterus (positive control tissue); N, autoclaved 
deionised distilled water (negative control sample) 
4.1.2.2 ER localisation using in situ RT-PCR 
When applying in situ RT-PCR, strong positive signals for the ER mRNA 
(Fig. 19a) were found in Sertoli and Leydig cells and germ cells except elongating/ed 
spermatids. In case of the ER (Fig. 19b) the staining pattern observed corresponded to the 
results obtained by IHC; distinct cytoplasmic signals were restricted to the spermatogonia 
and primary spermatocytes, only weak and fewer signals showed up in round spermatids 
and Leydig cells, elongated spermatids were negative. Negative controls were devoid of 
non-specific staining (Fig. 19c) while very strong nuclear signals from the genomic DNA 
were observed in the positive controls (Fig. 19d). 
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Fig. 19a: In situ RT-PCR for ER mRNA in 250-day old in mature boar testis showing distinct signals 
for ER-mRNA in spermatogonia (1), primary spermatocytes (2) and round spermatids (3). Mg=X400 
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Fig. 19b: In situ RT-PCR for ER mRNA in 250-day old boar testis. Strong cytoplasmic signals for 
ER-mRNA in spermatogonia (1) and primary spermatocytes (2) while round spermatids (3) Leydig cells 
showed no and/ or very weak signals. Mg=X400 
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Fig. 19c: Negative control for in situ RT-PCR for estrogen receptor mRNA in 250-day old boar 
testis. No staining after in situ-RT-PCR (primers omitted). Mg=x200 
 
 
Fig. 19d: Positive control for in situ RT-PCR for estrogen receptor mRNA in 250-day old boar 
testis; positive control: omission of DNAse treatment showing nuclear signals due to amplification of 
genomic DNA sequences (blue arrow). Mg=X400 
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4.2 Expression of P450 aromatase by IHC 
In all age groups the P450 aromatase immunoreactivity was found exclusively in 
the cytoplasm of Leydig cells. However an increase in both the number of positive cells 
and the intensity of the staining was observed with increasing age of the boars (Fig. 20a-e, 
Table 15a-c). 
4.2.1 P450 aromatase in 50-day old boars 
In this group of boars intense P450 aromatase immunoreactivity was found in 
67.81%±2.29 of Leydig cells (arrow 1) while in the rest a weaker or no reaction (arrow2) 
was observed (Fig. 20a). 
 
Fig. 20a: Immunolocalisation of P450 aromatase in the 50-day old boar testis showing strong 
positive signals in the cytoplasm of some of the Leydig cells (arrow 1) and weaker and/ or no signal in 
others (arrow 2). Mg=X200 
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Table 15a: Leydig cells staining positive for P450 aromatase in 50-day old boars 
 
Leydig cells counted 
 Boar  Slide Positive Negative Total %Positive Average 
E1 A 68 52 120 56.7   
  B 81 24 105 77.1   
  C 83 51 134 61.9         65.25 
            
E2 A 81 38 119 68.1   
  B 65 33 98 66.3   
  C 82 45 127 64.6 66.32  
            
E3 A 73 37 110 66.4   
  B 84 26 110 76.4   
  C 78 44 122 63.9 68.89  
            
E4 A 86 40 126 68.3   
  B 73 32 105 69.5   
  C 65 21 86 75.6 71.12  
            
E5 A 76 41 117 65.0   
  B 48 21 69 69.6   
  C 89 42 131 67.9 67.49  
Mean ( ) = 67.81, Standard deviation (SD) = 2.29 
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4.2.2 P450 aromatase in 100-day old boars 
In this group of boars intense P450 aromatase immunoreactivity was found in 
75.84%±1.65 of Leydig cells (arrow 1) while in the rest a weaker or no reaction (arrow 2) 
was observed (Fig. 20b). 
 
Fig. 20b: Immunolocalisation of P450 aromatase in the 100-day old boar testis showing strong 
positive signals in the cytoplasm of some of the Leydig cells (arrow 1) and weaker and/ or no signal in 
others (arrow 2). Mg=X200 
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Table 15b: Leydig cells staining positive for P450 aromatase in 100-day old boars 
Leydig cells counted 
 Boar Slide Positive Negative Total %Positive Average 
E1 A 76 35 111 68.5   
  B 80 15 95 84.2   
  C 78 30 108 72.2          74.97 
            
E2 A 84 29 113 74.3   
  B 79 33 112 70.5   
  C 77 25 102 75.5 73.45  
            
E3 A 76 26 102 74.5   
  B 71 20 91 78.0   
  C 75 22 97 77.3 76.62  
            
E4 A 72 20 92 78.3   
  B 69 21 90 76.7   
  C 64 18 82 78.0 77.66  
            
E5 A 73 21 94 77.7   
  B 70 25 95 73.7   
  C 79 22 101 78.2 76.52  
Mean ( ) = 75.84, Standard deviation (SD) = 1.65 
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4.2.3 P450 aromatase in 150-day old boars 
In the 150-day old group of boars, the intensity of P450 aromatase 
immunoreactivity was stronger than for the day-50 and -100 groups and again the number 
of negative Leydig cells decreased (arrow 2), with the positive cells increasing to 
87.52%±1.08 (arrow 1) (Fig. 20c). 
 
Fig. 20c: Immunolocalisation of P450 aromatase in the 150-day old boar testis showing positive 
signals in the cytoplasm of Leydig cells (arrow 1) and some cells with and/ or without signals (arrow 2). 
Mg=X200 
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Table 15c: Leydig cells positive for P450 aromatase in 150-day old boars 
Leydig cells counted 
 Boar Slide Positive Negative Total %Positive Average 
E1 A 89 16 105 84.8   
  B 86 13 99 86.9   
  C 90 11 101 89.1         86.91 
            
E2 A 92 12 104 88.5   
  B 87 15 102 85.3   
  C 93 8 101 92.1 88.61  
            
E3 A 91 16 107 85.0   
  B 90 9 99 90.9   
  C 88 13 101 87.1 87.69  
            
E4 A 94 10 104 90.4   
  B 89 14 103 86,4   
  C 91 12 103 88.3 88.38  
            
E5 A 86 11 97 88.7   
  B 84 14 98 85.7   
  C 92 18 110 83.6 86.00  
Mean ( ) = 87.52, Standard deviation (SD) = 1.08 
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4.2.4 P450 aromatase in 200- and 250-day old boars 
In these boars the intensity of P450 aromatase immunoreactivity was stronger than 
for groups of younger animals and literally all Leydig cells were positive (arrow 1) 
(Fig. 20d). 
 
Fig. 20d: Immunolocalisation of P450 aromatase in the 200-day old boar testis showing positive 
signals in the cytoplasm of all Leydig cells (black arrow). Mg=X100 
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Fig. 20e: Immunolocalisation of P450 aromatase in the 250-day boar testis showing at higher 
magnification positive signals in the cytoplasm of all Leydig cells (blue arrow). Mg=X400 
4.2.5 Detection of aromatase-Specific mRNA 
In vitro RT-PCR detected one specific band of aromatase mRNA with the expected 
number of base pairs (Table 6) in samples from all age groups (Fig. 21). 
 
Fig. 21: Ethidium bromide-stained agarose gel of in vitro RT-PCR analysis for the presence of 
mRNA specific to P450 aromatase. 1 = 50 days, 2 = 100 days, 3 = 150 days, 4 = 200 days and 
5 = 250 days testicular samples; M, DNA ladder; N, autoclaved double deionised water (negative control 
sample) 
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4.3 Expression of Steroid sulfatase and estrogen sulfotransferase 
4.4.1 Immunolocalisation of Steroid Sulfatase (StS) by IHC 
In all age groups (50-250 days) (Fig. 22a-e), StS was detected only in the 
cytoplasm of the Leydig cells. Apart from in day-50 group, in which 65.17±4.9% Leydig 
cells were positive (Table 16), StS expression in the other age groups remained relatively 
constant through out the age groups and literally all the Leydig cells were stained. 
 
Fig. 22a: StS expression in 50-day old boar testis showing signals in the cytoplasm of the Leydig cells 
(black arrow). Mg=X100 
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Table 16: Leydig cells staining positive for StS in 50-day old boars 
Leydig cells counted 
 Boar Slide Positive Negative Total %Positive Average 
E1 A 71 37 108 65.7   
  B 78 40 118 66.1   
  C 69 47 116 59.5     63.78 
            
E2 A 64 39 103 62.1   
  B 66 43 109 60.6   
  C 60 37 97 61.9 61.51  
            
E3 A 68 48 116 58.6   
  B 79 47 126 62.7   
  C 75 52 127 59.1 60.12  
            
E4 A 67 37 104 64.4   
  B 68 30 98 69.4   
  C 74 28 102 72.5 68.79  
            
E5 A 71 30 101 70.3   
  B 74 28 102 72.5   
  C 75 29 104 72.1 71.65  
Mean ( ) = 65.17, Standard deviation (SD) = 4.90 
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Fig. 22b: StS expression in 100-day old boar testis showing signals in the cytoplasm of the Leydig cells 
(black arrow). Mg=X200 
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Fig. 22c: StS expression in 150-day old boar testis showing at a higher magnification signals in the 
cytoplasm of the Leydig cells (black arrow). Mg=X400 
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Fig. 22d: StS expression in 200-day boar testis showing signals in cytoplasm of the Leydig cells (blue 
arrow).Mg=X200 
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Fig. 22e: StS expression in 250-day old boar testis showing at a higher magnification signals in the 
cytoplasm of the Leydig cells (blue arrow). Mg=X200 
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4.4.2 Detection of Steroid Sulfatase-Specific mRNA 
4.4.2.1 In vitro RT-PCR 
Detection of a single StS-specific band by RT-PCR (Fig. 23) confirmed the 
presence of StS on the mRNA level. 
 
Fig. 23: Ethidium bromide-stained agarose gel of in vitro RT-PCR analysis for the presence of 
mRNA specific to StS. 1 = 50 days, 2 = 100 days, 3 = 150 days, 4 = 200 days and 5 = 250 days 
testicular samples; M, DNA ladder; N, autoclaved double deionised water (negative control sample) 
4.4.2.2 Porcine StS gene sequence and in situ hybridisation 
As indicated in materials and methods (section 3.5.2), probes for in situ 
hybridisation were generated by using an approppriate vector-system, inserted into 
competent E.coli. As the sequence of porcine StS was not known and in order to obtain 
specific primers for RT-PCR, an alignment of the human StS Open Reading Frame 
sequence (GenBank AccNo: M16505) against porcine genomic sequence available online 
was performed. The sequence resulting from this alignment was then used to design 
primers for PCR and to generate probes for in situ hybridisation. The Partial sequence of 
the Open Reading Frame for the Pig StS gene sequence (see below) was submitted to the 
gene bank (GenBank AccNo: DQ139314) and is available online (Mutembei et al., 2005a). 
Partial sequence of the Open Reading Frame for the Pig StS 
ctgggaagga ggcatccgag tcccaggcat cctgaggtgg ccaggagtga 
tccaggcagg gctggagctt gatgcaccta caagcaacat ggacctgttt 
cctacggtgg ccaacctcgc cggggcccct ctgccggaag acaggatcat 
tgacggacgt gacctgatgc ccctgcttct agggcaaagc cagcattctg 
atcatgagtt tctcttccac tactgcaact tctatctgaa cgccgtacgc 
tggcacccac ggaacagcac gtccatctgg aaagccttct tcttcacacc 
caagttctcc cccgagggcg ccaatggatg ctttgccaca cacgtgtgct 
tctgtcacgg gcattccatc acccaccacg accctccttt gctgtttgac 
atctcccaag acccgcgaga gacagacccg ttaactccga catccgagcc 
ccggttctgg gagatcctgg ag 
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StS mRNA was detected only in the cytoplasm of the Leydig cells (Fig. 24 a) and 
there was no non-specific staining (Fig. 24b) in the negative control (antisense probe). 
(a) The positive probe 
 
Fig. 24a: Expression of StS-specific mRNA in 250-day old boar testis showing positive signals in 
cytoplasm of the Leydig cells (black arrow).Mg=X200 
(b) The negative probe 
 
Fig. 24b: Negative control (antisense) for expression of StS-specific mRNA in 250-day old boar 
testis with no traces of non-specific signals. Mg=x100 
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4.4.3 Immunolocalisation of Estrogen sulfotransferase (EST) by IHC 
In all age groups EST expression was restricted to the cytoplasm of the Leydig cells 
(Fig 25a-e). The intensity of expression and the number of positive cells remained 
relatively constant up to an age of 150 days with 71.87±1.66% of the Leydig cells being 
positive (Table 17a). Thereafter the number of positive cells decreased significantly 
(P≤0.05) to 57.21±0.56% in the day-200- and 250 age groups. 
4.4.3.1 EST in 50-day old boars 
 
Fig. 25a: EST expression in 50-day old testis showing strong signals in cytoplasm of the Leydig cells 
(blue arrow). Mg=X200 
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Table 17a: Leydig cells staining positive for EST in 50-150 day old boars 
Leydig cells counted 
 Group Boar Positive Negative Total % Positive Group 
mean 
Group 
std 
Day 50 E1 83 31 114 72.8    
 E2 80 29 109 73.4    
 E3 81 30 111 73.0 73.06  0.31 
             
Day 100          E1 80 35 115 69.6   
 E2 79 40 119 66,4    
 E3  88 31 119 73.9 69.97 3.76  
             
Day 150          E1 79 32 111 71.2   
 E2 78 28 106 73.6    
 E3  81 30 111 73.0 72.58 1.25  
Overall mean ( ) = 71.87, Standard deviation (SD) = 1.66 
 
Table 17b: Leydig cells staining positive for EST in 200-250 day old boars 
Leydig cells counted 
 Group Boar Positive Negative Total %Positive Average SD 
Day 
200  
E1 63 45 108 58.3    
 E2 60 42 102 58.8    
 E3 59 47 106 55.7     57.61 1.66 
             
Day 
250  
E1 65 46 111 58.6   
 E2 60 48 108 55.6    
 E3 58 45 103 56.3 56.81 1.57  
Overall mean ( ) = 57.21, Standard deviation (SD) = 0.56 
RESULTS  
   
122 
 
 
 
 
 
Fig. 25b: EST expression in 100-day old testis showing signals in cytoplasm of the Leydig cells (blue 
arrow). Mg=X200 
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Fig. 25c: EST expression in 150-day old testis showing signals in cytoplasm of the Leydig cells (blue 
arrow). Mg=X200 
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Fig. 25d: EST expression in 200-day old testis showing signals in cytoplasm of the Leydig cells (blue 
arrow). Mg=X200 
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Fig. 25e: EST expression in 250-day old testis showing signals in cytoplasm of the Leydig cells (blue 
arrow). Mg=X200 
4.4.4 Detection of Estrogen sulfotransferase-specific mRNA (RT-PCR) 
4.4.4.1 In vitro RT-PCR 
Detection of a single EST-specific band by RT-PCR (Fig. 26) confirmed the 
presence of EST on the mRNA level. 
 
Fig. 26: Ethidium bromide-stained agarose gel of in vitro RT-PCR analysis for the presence of 
mRNA specific to EST. 1 = 50 days, 2 = 100 days, 3 = 150 days, 4 = 200 days and 5 = 250 days 
testicular samples; M, DNA ladder; N, autoclaved double deionised water (negative control sample) 
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5. DISCUSSION  
5.1 Experimental design 
Although the boar testis secretes high amounts of estrogens, up to date only little 
information has been available on their possible biological importance (Claus and 
Hoffmann 1980, Claus et al., 1985, Raeside et al., 1999, Rostalski et al., 2000). In 
particular no information was available on a testicular significance in this species before 
this study. Estrogens act via their receptors (ERs) and hence in order to assess their 
biological activities in the boar testis, the present study aimed at investigating for the ER 
and ER as well as confirming expression of P450 aromatase (P450 arom), a key enzyme 
along the route of estrogen biosynthesis. In addition, expression patterns for two enzymes 
likely to alter bioavailability of testicular estrogens [steroid sulfatase (StS) and estrogen 
sulfotransferase(EST)] were studied. Immature and mature boars were tested to track the 
presence of these proteins and/or their mRNA with age of development and 
spermatogenesis. 
5.2 Methods 
5.2.1 Immunohistochemistry (IHC) 
The present study utilized IHC to detect the cellular location of ERs, P450 arom, 
StS and EST proteins using appropriate antibodies (Table 4). This method is routinely 
applied to make use of its advantage of requiring very little probe material (Thorpe 1987, 
Pertschuk et al., 1990). However, unlike in vitro enzyme assay systems e.g. receptor-ligand 
binding tests that are usually quantitative, the IHC method is qualitative and also suffers a 
set back of the likelihood to detect non-specific signals from cross-reacting proteins. A 
further drawback is the fact that antigens may be masked due to tissue conservation, 
requiring the somewhat obscure procedures of antigen retrieval (see in page 60). In spite of 
these problems, IHC at present is the only applicable method for localisation of tissue 
proteins and can not be substituted by in situ hybridisation studies, which measure mRNA 
levels but do not determine whether the mRNA is translated to the protein. In the present 
study use of available antibodies directed against ER and ER were expected to allow for 
discrimination between the ER subtypes. In addition to the declared specificity of a given 
antibody, IHC also requires further specifications, like the setting of negative control 
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sections using irrelevant isotype-specific antiserum from the same species in which the 
primary antibody was raised; absence of positive signals in the negative controls is an 
indicator of specificity. In addition, the observation that a reference tissue  known to 
express the protein (positive control) would show the expected patterns of expression when 
applied, greatly support specificity of the binding of the antibody and argues for the 
presence of protein to be assessed in the probe tissue (Thorpe 1987). 
In the present study porcine uterus was used as the reference tissue (Sierralta and 
Thole 1996) for ERs and the respective appropriate irrelevant isotype-specific isotypes 
(Table 4) were utilized to set up the negative controls. Mouse monoclonal antibody (clone 
HT277) directed against amino acids 532-554 of the pig ER, domain E (Sierralta and 
Thole 1996), which is not shared by ER was used for ER. For ER, a mouse 
monoclonal antibody against the highly conserved carboxy terminus of the human ER1 
(clone PPG5/10) was used. It is worthy noting here that monoclonal types of antibodies are 
more specific than the polyclonal types and more so, both of the antibodies used for the 
present study have been previously utilized to detect the ER subtypes in other species using 
both western blot and IHC methods; the ER antibody had been previously used to detect 
ER in bovine uterus and placenta (Sierralta and Thole 1996, Schuler et al., 2002) and the 
ER antibody to detect ER in the pig epididymis (Carpino et al., 2004). No reference 
tissues were used for P450 arom studies because the interest was only to confirm the 
localisation of P450 aromatase (Conley et al., 1996). For StS and EST the respective 
enzyme activities have been demonstrated in boar testicular tissue in earlier studies 
(Rostalski et al., 2000). 
5.2.2 In situ RT-PCR and in situ hybridisation 
In situ RT-PCR detects incorporated DIG-labelled uridine triphosphate (11-dUTP) 
in the DNA amplified in situ. It is a relatively new molecular biological technique showing 
a high sensitivity (Sander et al., 1996, Schiller et al., 1998). It shares the advantage of in 
situ hybridization that enables precise localization and identification of individual cells that 
contain specific nucleic acid sequences of interest, however, it has the advantage of being 
faster, simpler and having reduced costs of running (Komminoth et al., 1992). In this 
technique, specific complementary primers are used to amplify the target gene-DNA in 
tissue sections into high molecular concatemers, which then prevents diffusion of the PCR 
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product out of the cell during thermocycling and enables detection of gene-specific DNA 
signals that are complementary to the targeted gene-mRNA (Nuovo 1996). In our study we 
used porcine ER-specific primers from the published pig mRNA sequences (Table 3). 
5.2.3 In vitro RT-PCR and sequencing 
In vitro RT-PCR is a molecular technique used routinely to qualitatively detect 
gene expression (mRNA) within tissues or organs. In many cases, the amount of product 
detected in the gel is not related to the amount of input DNA (mRNA in the tissue) making 
it just an indicator tool for detecting the presence or absence of a particular mRNA. Except 
for StS where a partial sequence of the Open Reading Frame had to be cloned (see 4.4.2.2), 
the present study utilized primers designed from published porcine-specific mRNA 
sequences (Table 3) and the PCR products were subsequently sequenced to confirm 
homology with those of the genes published in the gene bank. 
5.3 Results 
5.3.1 Estrogen Receptors 
In the present study expression of the ER and ER in the porcine testis (see a 
summary below in Table 18) was demonstrated at both the protein and mRNA level. 
Conventional RT-PCR detected mRNA for both receptor isotypes in all age groups and the 
type and distribution pattern of ER mRNA and ER protein expressing cells was identical 
when applying in situ RT-PCR and IHC. This indicates that both transcription and 
translation occur in the same cells; it also points to the specificity of the IHC method 
applied. Specificity of IHC was further confirmed by lack of non-specific signals in the 
negative controls and by the results observed in the positive control (porcine uterus), which 
were consistent with the findings described previously for this tissue (Sierralta and Thole 
1996, Qualmann et al., 2000). 
Table 18: Summarized Expression of ER and ER in the boar testis. 
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The observed expression of the ER (Table 18) in the nucleus of prespermatogonia 
in the testis of immature boars (50 days of age) is consistent with similar observation in 
neonatal rodents and prepubertal humans (Enmark et al., 1997, Saunders et al., 1998, 
Pelletier and El-Alfy 2000, Katzenellenbogen and Katzenellenbogen 2000, Takeyama 
et al., 2001). However, other than in the neonatal rodent, with ER expressing Sertoli and 
Leydig cells (Saunders et al., 1998, Katzenellenbogen and Katzenellenbogen 2000), or in 
the prepubertal human, with ER expressing Sertoli cells (Enmark et al., 1997, Pelletier 
and El-Alfy 2000, Takeyama et al., 2001), in the immature boar Leydig and Sertoli cells 
were negative. 
Different from the ER (Table 18), the ER was detected not only in the 
prespermatogonia but also in Leydig cells of the immature boar. This conforms to 
observation in the juvenile rat (O'Donnell et al., 2001) and prepubertal human (Enmark 
et al., 1997, Pelletier and El-Alfy 2000, Takeyama et al., 2001) where expression of ER 
in prespermatogonia had been reported. However, unlike in the boar, the Leydig cells were 
negative in these two species (Enmark et al., 1997, Pelletier and El-Alfy 2000, O'Donnell 
et al., 2001, Takeyama et al., 2001). Another specific observation relates to the fact that 
ER seems to be the main ER isoform in the testis of immature rats and humans (Enmark 
et al. 1997, Pelletier and El-Alfy 2000, O'Donnell et al., 2001, Takeyama et al., 2001), 
while in the immature boar no differences were observed in the expression of the ER and 
ER in prespermatogonia. These observations point towards differences between species. 
Thus in the immature boar both ER isotypes may be important factors during the postnatal 
testicular development and onset of spermatogenesis, but only the ER influences Leydig 
cell functions. 
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With exceptions of elongating/ed spermatids, in sexually mature boars (100-250 
days of age), the ER was clearly expressed in virtually all germ cells undergoing the 
development from spermatogonia to round spermatids. Also the majority of Sertoli and 
Leydig cells were ER-positive. This observation is in agreement with results reported for 
adult rodents, primates, goats, dogs, cats and human (Goyal et al., 1997, Pentikainen et al., 
2000, Takeyama et al., 2001, Nie et al., 2002, Hess and Carnes 2004). There were only 
little variations in staining intensity and expression of the ER seemed rather 
homogeneous within and between cell types and there were no apparent relations to the 
stage of spermatogenesis. These data obtained on the protein level were confirmed on the 
mRNA level indicating, that transcription and translation of ER occurs in the positive 
staining cells. Similar and confirmatory evidences on ER data have been obtained by 
Rago et al. (2004). 
With respect to the ER, spermatogonia and primary spermatocytes showed a 
strong immunostaining with 93.6 ± 2.7% of these cells being positive while the secondary 
spermatocytes and round spermatids exhibited weak staining with 51.4 ± 0.27% of the 
cells being positive; again elongating/ed spermatids were negative. In situ RT-PCR 
confirmed the expression pattern for both the ER and ER. These observations indicate 
that transcription and translation of the ER in secondary spermatocytes and round 
spermatids may be down-regulated and/or that a part of the weakly immunostaining 
positive cells when applying IHC might be a result of a carry over of the receptor protein 
from the preceding developmental stages. Again, no relationship was observed between the 
IHC-staining pattern for the ER and the stage of spermatogenesis. These data have been 
reported (Mutembei et al., 2005b) and to our knowledge, these are the second data 
reporting expression of ER in germ cells of mammals, which agrees with a previous one 
on humans (Pentikainen et al., 2000). Similar and confirmatory evidences on these data 
have been obtained by Rago et al. (2004) and by Lekhkota et al. (2006). The predominant 
expression of ER in the spermatogonia and primary spermatocytes of the boar so far 
seems to be unique for this species. However, in accordance with observations in other 
species (Hess and Carnes 2004), also in the boar Leydig and Sertoli cells express the ER. 
The results of the present study revealed a unique distribution pattern of ER in 
somatic and germ cells of young and adult boar testis, confirming the species-specific 
gonadal expression of estrogen receptors. However, as in other investigated species, the 
cellular ER distribution in boar testis appears to be developmentally regulated. This agrees 
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to the data demonstrating that puberty can also influence the ER expression in epithelial 
cells of boar epididymis (Carpino et al., 2004). 
The involvement of estrogen receptors in development and functional activity of 
boar testes is unknown. Recently, it has been reported that there is a functional linkage 
between ER and embryonic growth of pigs (Kowalski et al., 2002). Therefore, our study 
represents a basic foundation to investigate the role of ERs in porcine male gonads. In fact, 
the variable ER/ER immunostaining pattern in testicular somatic and germ cells as well 
as in immature and mature gonads suggests that estrogens could modulate spermatogenesis 
and testis development via a differential expression of the two estrogen receptor subtypes. 
Further studies investigating the expression patterns of the various ER isoforms in 
testicular cells could provide greater understanding of the gonadal maturation mechanism 
in pig. 
The exact mechanism through which estrogen receptors regulate testicular function 
is unknown. However there is a general agreement that ERs function as dimers, and co-
expression of ER and ER in the same cell causes the formation homodimers (ER/ER 
and ER/ER) or heterodimers (ER/ER), which affect ligand-specificity. For example, 
some agonists bind both ER subtypes with the same affinities, while others bind 
preferentially to ER or ER (Dechering et al., 2000, Gronemeyer et al., 2004). The 
interactions between ERs, their ligands and estrogen responsive elements (EREs) are 
complicated by other factors, including the ability of ER to modulate ER transcriptional 
activity and the recruitment of several protein co-activators and repressors by both ER sub 
types. Therefore, the relative amounts of ER and ER in a given tissue (testis included) 
are key determinants of cellular responses to estrogen and other ER agonist and antagonist 
(Gustafsson 2003, Gronemeyer et al., 2004), particularly also in respect to the activity of 
environmental endocrine disruptors with estrogenic activity (Toppari et al., 1996, Cooper 
and Kavlock, 1997, Toppari et al., 1996). 
In female organs and the prostate, it is now well established that ERs achieve 
genomic responses by regulating expression of target genes with either classical estrogen 
responsive elements (ERE) or with alternative promoter elements such as CRE and AP1 
that bind heterologous transcription factors (Kushner et al., 2003). Mammalian ER target 
genes e.g. prolactin, cathepsin D and lactoferrin contain classical estrogen responsive 
elements (ERE) within the promoter regions that allow ERs to bind to DNA and regulate 
transcription. On the other hand, the cyclin D1 gene is a very important ER-induced gene 
DISCUSSION 
   
132 
that is regulated at alternative promoter elements CRE and AP1. The cyclin D1 gene has 
been implicated as the principal mode for estrogen-mediated growth, both of breast cells in 
vitro and of mammalian epithelial cells in vivo (Peach et al., 1997). Moreover, the ER has 
the ability to mediate biological effects through non-transcriptional mechanisms mediated 
by protein-protein interactions between them and growth factors (Kuschner et al., 2003). 
Membrane-bound ERs signalling via protein kinase C (PKC) and mitogen-activated 
protein kinases (MAPK) pathways have been shown to induce epithelial cell proliferations 
(Collin and Webb 1999). Thus, although the physiological significance of specific 
pathways in the testis remains to be elucidated, estrogen action in any particular tissue and 
organ is the result of activities mediated by an integration of several genomic and non-
genomic pathways (Akingbemi 2005, Bjornstrom and Sjoberg 2005). 
In some species e.g. rat, mice, monkey, man and horse (Shughrue et al., 1998), 
testicular estrogens have been shown to act at the hypothalamus to affect GnRH pulses, 
and at pituitary level to regulate gonadotropin (FSH and LH) secretion. Estrogen regulation 
of LH in these species occurs directly via the EREs contained on the promoter region of -
subunit of LH gene (Shupnik et al., 1988). On the other hand, in some species like it is the 
case for the boar, estrogens do not appear to play a regulatory role on gonadotropin 
secretion (Shupnik et al., 1988, At-Taras et al., 2006a). Recently it emerged clearly for the 
first time that not only that testis and sperm production are influenced by endogenous 
estrogen secretion in the boar, but that inhbiting estrogen synthesis can increase these 
parameters by over 20% (At-Taras et al., 2006b). Thus, in the boar, it is now evident that a 
direct rather than an indirect action of estrogens in the testis seems to occur. Testes of 
aromatase-inhibited boars initially exhibited delayed lumen formation, lower testicular 
weight, fewer detergent-resistant spermatids, and fewer Sertoli cells, but by 7 to 8 months, 
the boars had recovered and had larger testes (At-Taras et al., 2006b). Thus, reducing 
endogenous estrogen production in the boar causes a delay in testicular maturation/puberty 
that allows for a longer window for proliferation of Sertoli cells and maturation of Leydig 
cells, resulting in larger testes and higher spermatid production. 
In summary, the biological significance of estrogen receptors expressed in the male 
genital tract and the testis still needs to be clarified and thus requires a careful 
interpretation. For example, although levels of ER are greater than those of ER in the 
male gonad, mice lacking the ER are fertile and have normal genital tissues (Krege et al., 
1998; Dupont et al., 2000). Otherwise mice lacking ER are infertile and exhibit 
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remarkable morphological abnormalities of the reproductive system (Eddy et al., 1996, 
Hess et al., 2000). It has been proposed that ER could act as a negative regulatory partner 
for ER (Weihua et al., 2000) and a “Ying-Yang” balance between ER and ER 
suggested for normal functioning of the testis (Lindberg et al., 2003). In the human, in 
some individuals a lack of ER expression has been reported in both immature and adult 
testes (Makinen et al., 2001, Gaskell et al., 2003) and normal testes and normal sperm 
density have been observed in an ER-deficient man (Smith et al., 1994). Therefore ER 
could be the receptor mediating the effect of estrogens in human testes. The recent 
discovery of different human ER isoforms with distinct cell specific expression patterns 
(Gaskell et al., 2003, Saunders et al., 2002, Scobie et al., 2002) makes the interpretation of 
estrogen receptor expression in male gonads even more difficult. Furthermore, the obvious 
differences in the phenotypes of ArKO, ERKO, ERKO and ERKO mice, as were 
determined in early studies, implies that none of the two ER-subunits is the sole mediator 
of estrogen action. For example, ER inactivation had no effect on number of 
spermatogonia whereas ER inactivation increased the number of spermatogonia by more 
than 50% in neonatal mice (Delbes et al., 2004). In this case, ER seems to be a modulator 
of ER function, a function that is generally implicated for ER in the testis. However, in 
general, both the ER and the ER seem to have varying functions that also could be 
species dependent. 
5.3.2 Aromatase 
In agreement with previous observations (Conley et al., 1996; Carreau et al., 1999; 
Fraczek et al., 2000), our data confirm that the expression of aromatase is restricted to the 
Leydig cells, which also express the ER and ER. Thus, in the boar testicular estrogens 
seem to be autocrine and/or intracrine factors controlling Leydig cell function while Sertoli 
cell function and spermatogenesis might be affected by paracrine mechanisms. Although in 
some species, like rodents and equines, where aromatase is also expressed in other cell 
lines like germ cells, in the boar aromatase is solely expressed by the Leydig cells. 
5.3.3 StS and EST 
As has been shown for the mouse, rat and man (Song et al., 1995, 1997, Munroe 
and Chang 1997), the present study revealed that also in the boar, data from EST is 
expressed in Leydig cells. Leydig cells also expressed StS and like it was the case for the 
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rat and the mouse, this enzyme is also coexpressed with the aromatase system in the boar 
(Conley et al. 1996; Carreau et al. 1999, Fraczek et al. 2000, Mutembei et al., 2005b). 
Thus, in the boar, the Leydig cells houses EST, StS and aromatase. For a functional 
interpretation of these observations further studies are necessary. However, colocalisation 
of StS and aromatase in the Leydig cell seems to suggest that StS enzyme might be 
important in the hydrolysis of precursor steroids during testicular steroidogenesis. 
However, a direct role in the hydrolysis of E1S to E1, as it was demonstrated in human 
breast cancer cells (Chandra 2003) cannot be ruled out. 
Based on the facts that cultured Leydig cells of the boar (Reaside 1983) have been 
shown to conjugate estrone and EST activity has been demonstrated in the boar testicular 
homogenates (Rostalski 2005), it was not surprising that Leydig cells expressed EST. 
However, the biological significance of this expression needs careful interpretation. In the 
boar conjugation of estrogen occurs not only within the Leydig cells (Reaside 1983) but 
also in the periphery (Booth 1984) and in the epididymis, vas deferens, seminal vesicle and 
the prostate (Reaside et al., 1999). Therefore, in accordance to Claus et al. (1985), who 
found higher concentrations of E1 than of EIS in testicular tubular fluid, and in respect to 
the lower activity of EST determined in the testis compared to the epididymis (Rostalski et 
al., 2000) and the local circulatory system (Rerkamnuaychoke et al., 1991, Pinart et al., 
2001a), rather the epididymis than the testis seems to be the origin of the high E1S-
concentrations determined in the testicular vein plasma (Rostalski 2005, Claus et al., 
1987). Probably conjugations within the Leydig cells might be only for homeostasis 
purposes. In any case, if active conjugation of estrogens occurs within the Leydig cells, the 
conjugated estrogens would be either locked in there or require active transporters for their 
exocytosis.  
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6. THESIS ABSTRACT 
Estrogen action is mediated via estrogen receptor proteins (ERs). ERs occur in two 
forms, the classical ER subtype and the novel ER discovered in 1996. These proteins 
are also widely expressed in the male reproductive tract. Recent data from transgenic mice 
deficient in estrogen receptors or aromatase, points to an essential physiological role of 
estrogens for male fertility, which may, however, also be severely hampered by the 
administration of estrogens and xenoestrogens during fetal and neonatal development. 
These observations raise the question on the mechanisms of action of estrogens in the 
male. 
Together with the stallion the boar secretes remarkably high amounts of testicular 
estrogens. The present study was based on the hypothesis that these estrogens are likely to 
have local activity and hence designed to provide basic information on sources and targets 
of estrogens in the boar testis to set a foundation for further studies on their biological 
significance. In order to achieve this information, expression and localisation of the ER 
and the ER, cytochrome P450 aromatase, steroid sulfatase (StS) and estrogen 
sulfotransferase (EST) in the testes of immature and mature boars was assessed. 
Immunohistochemistry (IHC) was applied to show cellular expression of proteins 
and either one-step in situ RT-PCR or in situ hybridisation was applied to localize 
cytological mRNA. Gene expressions were evaluated using qualitative RT-PCR. 
Testicular samples were collected from 25 healthy Large White boars. The animals 
were randomly obtained from 5 litters, allotted to five age groups (5 animals per group) 
and castrated at ages of 50, 100, 150, 200 and 250 days. Samples for IHC were preserved 
in phosphate buffered 4% formalin while those for RT-PCR were snap frozen in liquid 
nitrogen and stored at -80oC. Porcine uterine samples serving as positive controls were 
collected from the local slaughter house. 
The ER expression patterns showed qualitative and quantitative differences 
between and within immature (50 days old) and sexually mature (100 250 days old) 
animals. The ER immunoreaction signals were observed only in nuclei. In 50-day old 
boars, 90.6 ± 1.2% of prespermatogonia and 71.0 ± 2.6% of the Leydig cells showed a 
strong staining for ER; 95.5 ± 3.5% of the prespermatogonia but none of the Leydig and 
Sertoli cells were ER-positive. In 100-250-day old boars a strong staining for the ER 
was observed in virtually all Sertoli, Leydig and germ cells, except for the elongating/ed 
spermatids, which were clearly negative; for the ER, strong immunoreaction signals were 
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restricted to spermatogonia and primary spermatocytes with 93.6 ± 2.7% of these cells 
being positive; distinctly less intensive signals were observed in 51.4 ± 0.27% of the 
secondary spermatocytes and/ or round spermatids, Sertoli- and Leydig cells. In vitro RT-
PCR was positive for both receptors and results of in situ RT-PCR matched those obtained 
by IHC. P450 aromatase, steroid sulfatase and estrogen sulfotransferase expressions were 
restricted to the cytoplasm of Leydig cells, both at protein and mRNA localisation. 
The present study confirmed that Leydig cells of the boar are the only source of 
estrogens which could likely have local autocrine and/or paracrine activities via the 
available ER receptors (ER and ER). Apparently, availability of biologically active free 
estrogens seems to be modulated by the enzymes steroid sulfatase and estrogen 
sulfotransferase, both of which are expressed in the Leydig cells. The variable ER/ER 
immunostaining pattern in testicular somatic and germ cells of the gonads of immature and 
mature boars suggests that estrogens could modulate spermatogenesis and testis 
development via a differential expression of the two estrogen receptor subtypes. To 
validate these hypotheses further functional studies and studies dealing with subcellular 
localisation of the regulatory factors determined are necessary. 
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7. ZUSAMMENFASSUNG 
Die genomische Wirkung der Östrogene wird über nukleare Östrogen-Rezeptoren 
(ERs) vermittelt, deren Expression auch im männlichen Reproduktionstrakt nachgewiesen 
wurde. Die ERs kommen in zwei Formen vor, dem klassischen ER- und dem erstmals 
1996 nachgewiesenen ER-. Untersuchungen an transgenen Mäusen (ER Knockout, 
Aromatase Knockout) haben die essenzielle Bedeutung der Östrogene für die männliche 
Fortpflanzung dargelegt, wobei ebenfalls bekannt ist, dass die Applikation östrogen-
wirksamer Verbindungen, z.B. von Xenoöstrogenen, während der Embryonal- oder 
Fetalperiode zu schwerwiegenden Störungen der männlichen Reproduktion führen kann. 
Diese Beobachtungen werfen die Frage nach den dabei zugrunde liegenden 
Wirkmechanismen auf. 
Neben dem Hengst zeichnet sich der Eber durch eine bemerkenswert hohe 
Produktion testikulärer Östrogene aus, für die auch eine direkte Wirkung im Hoden 
unterstellt werden kann. Ziel der vorliegenden Studie war es daher, Herkunft und 
Zielzellen von Östrogenen im Eberhoden zu definieren, um Anhaltspunkte für eine 
mögliche biologische Wirkung testikulärer Östrogene zu erhalten und damit eine 
Grundlage für weiterführende Untersuchungen zu schaffen. Dazu sollte die Expression und 
Lokalisation der Östrogenrezeptoren ER- und ER-, der Aromatase (Cyp P450 arom), 
und der Enzyme Steroidsulfotransferase (Inaktivierung) und Steroidsulfatase (Aktivierung) 
dargestellt werden. 
Zur Darstellung der Expression auf der Proteinebene diente die Immunhistochemie 
(IHC). Qualitative RT-PCR, One - Step in situ RT-PCR und in situ hybridization (ISH) 
dienten der Feststellung der Expression und Lokalization auf mRNA Ebene. Zur 
Verfügung standen 25 Eber aus 5 Würfen, von denen nach randomisierter Zuteilung zur 
Gewinnung der Hoden jeweils 5 Tiere im Alter von 50, 100, 150, 200 und 250 Tagen 
kastriert worden waren. Gewebeproben wurden aus dem Hodenparenchym entnommen 
und für die IHC, One – Step in situ RT-PCR und ISH in 4%-igem Formol nach Lillie für 
20-24 Stunden fixiert und in Paraffin eingebettet; für die RT-PCR wurden die Proben 
schockgefroren (-196 oC) und danach bei -85 oC aufbewahrt. Als Kontrollgewebe dienten 
am lokalen Schlachthof gewonnene Schweineuteri. 
Die Expression der Östrogenrezeptoren zeigte qualitative und quantitative 
Unterschiede sowohl zwischen den noch nicht geschlechtsreifen (50 Tage) und den 
geschlechtsreifen Tieren (100-250 Tage) als auch innerhalb der Altersgruppen. 
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IHC-positive Signale waren auf die Kerne beschränkt, im Falle des ER waren bei den 50 
Tage alten Tiere 90,6  1,2 % der Präspermatogonien und 71,0  2,6 % der Leydigzellen 
positiv, im Falle des ER 95,5  3,5 % der Präspermatogonien, die Leydigzellen und 
Sertolizellen zeigten keine positiven Signale. Bei den 100-250 Tage alten Tieren ergab die 
IHC positive Signale für den ER in praktisch allen Sertoli-, Leydig- und Keimzellen, 
ausgenommen der elongierten/elongierenden Spermatiden, die eindeutig negativ waren. Im 
Falle des ER- waren deutliche IHC-positive Signale auf die Spermatogonien und 
primären Spermatozyten beschränkt, die zu 93,6  2,7% positiv waren. Positive Signale 
von allerdings wesentlich geringer Intensität ergaben sich für die sekundären 
Spermatozyten, runden Spermatiden, Sertoli- und Leydigzellen, die zu 51,4  0,27% 
positiv waren. Die in-vitro RT-PCR war positiv für beide Rezeptoren, die in situ one – step 
RT-PCR bestätigte die Ergebnisse der IHC. Die Expression der P450-Aromatase, der 
Steroidsulfatase und der Steroidsulfotransferase war auf das Zytoplasma der Leydig-Zellen 
beschränkt, sowohl auf der Protein-, als auch auf der mRNA- Ebene. 
Die auf die Leydigzellen beschränkte Expression der Aromatase bestätigt, dass 
allein diese Zellen im Hoden vom Eber zur Synthese von Östrogen befähigt sind, denen im 
Hinblick auf die dort ebenfalls festgestellte Expression des ER und ER mit hoher 
Wahrscheinlichkeit eine autokrine Wirkung zukommt. Dabei scheint die Verfügbarkeit von 
freiem, biologisch aktiven Estron durch die Expression der Steroidsulfatase und der 
Östrogensulfotransferase moduliert zu werden. Dies gilt sowohl für eine mögliche 
autokrine Wirkung, bezogen auf die Funktion der Leydigzellen, als auch für eine zu 
unterstellende parakrine Wirkung, bezogen auf die ER- und ER-positiven Zellen im 
restlichen Hodengewebe. Die unterschiendliche Expression des ER und ER in den 
somatischen Zellen und Keimzellen des Hodens bei immaturen und maturen Ebern legt 
nahe, dass den Östrogenen eine die Spermatogenese modulierende und die Entwicklung 
der Hoden betreffende Wirkung zukommt. Zur Untermauerung dieser Thesen sind 
weiterführende funktionelle Studien sowie Studien zur subzellulären Verteilung der 
erfassten Regelfaktoren notwendig. 
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9. ANNEXES 
Annex 1: Summary of immunohistochemistry protocol 
Day 1 
Alcohol (2x Xylol 5min, then 2min: 2x99%, 2x95%, 2x70%, 2x30%) 
5 min under running tap water; rinsing 
1x5 min 10mM (7.0 pH) Citrate buffer (pre-incubation at Room temperature) 
3x5 min Citrate buffer (heating at 560 Watt Microwave, covered in pre-heated buffer) 
1x20 min in Citrate buffer cooling 
5 min under running tap water; rinsing 
30 min 0.3% H2O2 in Methanol (2,5ml H2O2 30%+250ml Methanol) 
5 min with IHC buffer; rinsing  
Section drain and dry and wells made around sections using PAP-Pen 
20 min in a moist chamber incubation with blocking Serum; 70µl/section  
Drain and dry PAP-Pen 
Over night (20h) incubation with primary antibody at 4oC; 90l/section, in a moist chamber 
Day 2 
Drain antibody, then 2x10 min with ICC buffer; rinsing 
Drain and dry PAP-Pen, then apply secondary boitynylated antibody for 30 min, 90l/section 
Drain Ab 
10 min in ICC buffer rinse 
Drain and dry PAP-Pen, then 30 min ABC-System (Vector Laboratories, Burlingame, CA94010, USA), 
70l/section (5ml ICC buffer +2 drops of sol.A +2 drops of sol. B, note: must be set30 min before 
Drain and dry PAP-Pen  
10 min in ICC buffer rinse 
Drain and dry PAP-Pen  
Nova RED for 15 min, 90l/section (5ml distilled water+3 drops of sol.1+ 2drops of sol 2+ 2 drops of 
sol.3+ 2 drops of H2O2 ; mixed well after every sol. added. (Vector Laboratories, Burlingame, CA94010, 
USA) 
Drain and pap pen 
10 min under running water rinsing 
Counter stain with Hematoxylin, 30 sec.;  
5 min under running water rinsing 
Alcohol series (2X2min 80%, 2X2min 96%, 2X2min 99%,2X10min Xylene) 
Mounting in Eu-Kit (Assistant, D-35520 Osterode) 
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Annex 2: Summary of RNeasy Mini Kit RNA extraction procedure 
1) Prepare 3ml RTL buffer + 30µl -mercaptoethanol in a sterile glass tube 
2) Tissue preparation (as described above) 
3) Add 200 mg of the tissue in the glass tube with RTL+mercaptoethanol buffer (1 above) 
4) 3X30 sec ultraturrax homogenise 
5) Centrifugation; 10 min at RT at a speed of 4000-5000 g. 
6) 2 ml supernatant transferred to another glass tube + 2 ml %70 Ethanol (Vortex) 
7) Transferred the whole liquid into pink tubes, (specific for PCR- tissue preparation) and 
centrifugation; 10 min at RT at a speed of 4000-5000 g. 
8) Liquid that flows through the filter bottom is poured away, then 4ml RW1 is added and 
centrifugation; 10 min at RT at a speed of 4000-5000 g. 
9) Liquid that flows through the filter bottom is again poured away, then 2.5ml RPE Buffer is 
added and centrifugation; 2 min at RT at a speed of 4000-5000 g. 
10) Liquid that flows through the filter bottom is again poured away, then 2.5ml RPE Buffer is 
added and centrifugation; 2 min at RT at a speed of 4000-5000 g. 
11) Then the mRNA filter (pink filter) is transferred into another tube and 150µl RNAse free 
water is added and given an allowance of 1-10 min (wait for 1-10 min), then centrifugation; 3 min 
at RT at a speed of 4000-5000 g. 
12) The liquid that flows through is not poured away this time round! (This is your RNA) 
13) One can choose to repeat step 11; that is, add a further 150µl RNAse free water into the filter 
(wait for 1-10 min), then centrifugation; 3 min at RT at a speed of 4000-5000 g. 
14) Transfer the probe to the eppendorf tubes.  
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Annex 3: Protocol for ligation using pGEM-T-Vector 
1. Briefly centrifuge the pGEM®-T Vector and Control Insert DNA tubes to collect 
contents at the bottom of the tubes 
2. Set up ligation reactions as described below. Note: Use 0.5ml tubes known to have low 
DNA-binding capacity and vortex the 2X Rapid Ligation Buffer vigorously before each 
use. 
                                                 Standard        Control         
                                                 Reaction        Reaction        
------------------------------------------------------------------------- 
T4 DNA Ligase 10X Buffer                          1µl             1µl            
pGEM®-T Vector (50ng)                             1µl             1µl            
PCR product (or pGEM®-T Vector Control)           Xµl             2µl            
T4 DNA Ligase (1 Weiss unit/µl)                   1µl             1µl                
------------------------------------------------------------------            
dH2O to a final volume of                                                           10µl                         10µl            
3. Mix the reactions by pipetting and incubate the reactions 1 hour at room temperature. 
 
 
Annex 4: Bacteria transformation protocol 
1. Prepare 2 LB/ampicillin/IPTG/X-Gal plates for each ligation reaction. Equilibrate the 
plates to room temperature prior to plating  
2. Centrifuge the tubes containing the ligation reactions to collect contents at the bottom 
of the tube. Add 2µl of each ligation reaction to a sterile 1.5m- microcentrifuge tube 
on ice.  
3. Remove tube(s) of frozen Competent E. coli cells from–70°C storage and place in an 
ice bath until just thawed (about 5 minutes) Mix the cells by gently flicking the tube. 
4. Carefully transfer 50µl of cells into each tube prepared in Step 2  
5. Gently flick the tubes to mix and place them on ice for 20 minutes. Heat-shock the 
cells for 45–50 seconds in a water bath at exactly 42°C (Do Not Shake) Immediately 
return the tubes to ice for 2 minutes 
6. Add 950µl room temperature SOC medium to the tubes containing cells transformed 
with ligation reactions and 900µl to the tube containing cells transformed with uncut 
plasmid (LB broth may be substituted, but colony number may be lower).  
7. Incubate for 1.5 hours at 37°C with shaking (~150rpm).  
8. Plate 100µl of each transformation culture onto duplicate LB/ampicillin/ IPTG/X-Gal 
plates. For the transformation control, a 1:10 dilution with SOC medium is 
recommended for plating. If a higher number of colonies is desired, the cells may be 
pelleted by centrifugation at 1,000 × g for 10 minutes, resuspended in 200µl of SOC 
medium, and 100µl plated on each of 2 plates.  
9. Incubate the plates overnight (16–24 hours) at 37°C. In our experience, approximately 
100 colonies per plate are routinely seen when using competent cells that are 1 × 
108cfu/µg DNA, if 100µl is plated. Longer incubations or storage of plates at 4°C 
(after 37°C overnight incubation) may be used to facilitate blue colour development. 
White colonies generally contain inserts; however, inserts may also be present in blue 
colonies.  
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